Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014133	s-koirhie	— (—)	3716	3832	100.00%	Distribution not available
3014133	s-koirhie	kU/l (u/ml)	3626	3898	1.80%
3014133	koira,hils	— (—)	565	596	100.00%	Distribution not available
3014133	igekoira	kU/l (u/ml)	224	238	0.00%
3014133	s-koiranhilse,igevasta-aineet	kU/l (u/ml)	192	198	0.00%
3014133	koirae	kU/l (u/ml)	190	209	0.00%
3014133	koira,hils	kU/l (u/ml)	163	165	0.00%
3014133	s-koirhie	kU/l______ (u/ml)	61	61	0.00%
3014133	s-allige,koira(hilse)/hund(mjäll)osa	kU/l (u/ml)	51	52	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of upper respiratory tract

2056

3963

2.75

320.64

1.1

1.0

4.81

3.50

u/ml

1.89

1170

1763

Atopic dermatitis

1832

5191

2.90

307.65

1.1

7.57

2.92

u/ml

13.43

1151

2424

Asthma, including avohilmo

3621

4587

4.51

307.65

1.1

1.0

5.83

2.15

u/ml

20.48

2179

1993

Conjunctivitis

2072

6037

2.84

307.65

1.1

5.09

3.97

u/ml

1.61

1299

2884

Asthma (mode)

2427

2480

5.35

307.65

1.1

1.0

5.82

2.67

u/ml

10.28

1552

954

Asthma, unspecified (mode), excluding more controls

1206

2199

4.03

307.65

1.1

1.0

4.19

2.81

u/ml

2.03

689

840

Allergic asthma (mode)

1221

1642

7.86

307.65

1.2

1.0

8.08

2.95

u/ml

11.82

925

677

Asthma and allergy, excluding more controls

905

1057

9.50

307.65

1.2

1.0

9.21

2.83

u/ml

11.73

703

447

Allergic asthma (mode), excluding more controls

1220

1648

7.82

307.65

1.2

1.0

8.08

2.96

u/ml

11.79

925

679

Asthma, hospital admission 2, infections

1638

4226

3.91

307.65

1.2

1.0

6.73

2.86

u/ml

10.34

1089

1898

Vasomotor and allergic rhinitis

1964

3121

6.65

307.65

1.1

1.0

6.11

3.68

u/ml

5.13

1319

1409

Asthma-related infections

1638

4226

3.91

307.65

1.2

1.0

6.73

2.86

u/ml

10.34

1089

1898

Chronic lower respiratory diseases

3308

5015

3.58

307.65

1.1

1.0

5.97

2.43

u/ml

17.04

2032

2187

Asthma (diagnoses ohter than nonallergic)

2661

5676

3.92

307.65

1.1

1.0

6.30

2.76

u/ml

14.80

1766

2528

Pollen allergy

1468

2222

7.48

307.65

1.1

6.55

3.20

u/ml

5.99

1024

1063

1420

3566

4.12

307.65

1.2

1.0

7.13

3.00

u/ml

9.35

950

1630

Asthma

2412

2469

5.24

307.65

1.1

1.0

5.85

2.67

u/ml

10.31

1534

950

Allergic rhinitis

1861

3138

6.45

307.65

1.1

6.24

3.33

u/ml

6.26

1282

1439

Asthma, excluding more controls

2391

2448

5.22

307.65

1.1

1.0

5.86

2.68

u/ml

10.21

1519

941

Disorders of conjunctiva

2110

6176

2.71

307.65

1.1

5.03

3.93

u/ml

1.62

1317

2945

Asthma (only as main-diagnosis), excluding more controls

2383

2448

5.62

307.65

1.1

1.0

6.00

2.68

u/ml

10.78

1524

941

Asthma and allergy

905

1035

9.70

307.65

1.2

1.0

9.21

2.84

u/ml

11.62

702

438

Asthma (only as main-diagnosis)

2393

2469

5.65

307.65

1.1

1.0

5.98

2.67

u/ml

10.83

1531

950

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1732

5178

3.33

307.65

1.1

4.86

3.82

u/ml

1.59

1113

2401

Chronic rhinitis, nasopharyngitis and pharyngitis

869

2058

4.39

307.65

1.1

1.0

3.57

3.28

u/ml

0.18

496

912

Chronic sinusitis

1051

2647

4.10

307.65

1.1

1.0

2.85

3.33

u/ml

0.53

593

1138

Allergic conjunctivitis

1784

5485

3.25

307.65

1.1

4.82

4.01

u/ml

1.06

1146

2559

Asthma, unspecified (mode)

1212

2217

4.05

307.65

1.1

1.0

4.16

2.80

u/ml

2.01

693

848

Asthma/COPD (KELA code 203)

2668

4999

3.68

307.65

1.1

1.0

6.41

2.43

u/ml

16.88

1674

2182

Asthma, hospital admissions , main diagnosis only

2575

5822

4.00

307.65

1.1

1.0

6.18

2.94

u/ml

12.24

1679

2639

Atopic dermatitis, strict definition with reimbursement

1151

3431

3.38

295.38

1.1

9.73

3.03

u/ml

15.37

827

1664

Obesity related asthma

809

2010

4.17

289.94

1.1

1.0

5.73

2.22

u/ml

4.93

498

823

Desensitization to allergens

451

704

7.62

285.30

1.1

5.39

4.35

u/ml

0.54

324

369

Nasal polyp

448

741

6.30

259.19

1.2

1.0

3.32

2.93

u/ml

0.21

305

331

Dermatitis and eczema

2235

5842

2.30

252.94

1.1

6.40

2.77

u/ml

11.13

1313

2741

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1001

3063

3.22

244.63

1.1

1.0

3.37

3.24

u/ml

0.06

548

1333

Suggestive for eosinophilic asthma

287

340

9.01

225.50

1.2

1.0

3.56

2.31

u/ml

0.64

216

146

Atopic dermatitis, strict definition

1072

3778

2.90

212.79

1.1

10.35

3.27

u/ml

15.20

769

1878

Other pulmonary diagnosis

1354

2507

2.75

208.98

1.1

1.0

4.43

2.77

u/ml

1.96

744

974

COPD differential diagnosis

1332

2480

2.73

203.55

1.1

1.0

4.38

2.67

u/ml

2.03

735

954

ILD differential diagnosis

1330

2480

2.73

202.65

1.1

1.0

4.39

2.67

u/ml

2.04

734

954

Oral corticosteroids

2017

5496

2.18

201.64

1.1

5.31

3.46

u/ml

3.70

1191

2564

Excluding asthma or asthma-COPD overlap

1336

2507

2.71

201.23

1.1

1.0

4.48

2.77

u/ml

2.02

732

974

Undetermined asthma

334

552

6.31

193.33

1.1

1.0

2.89

1.97

u/ml

0.69

205

217

Undetermined asthma, excluding more controls

334

555

6.27

192.27

1.1

1.0

2.89

2.07

u/ml

0.58

205

220

Asthma, hospital admissions 3, pneumonia

633

1773

3.64

189.37

1.2

1.0

6.30

2.84

u/ml

3.39

430

779

Asthma-related pneumonia or sepsis

633

1773

3.64

189.37

1.2

1.0

6.30

2.84

u/ml

3.39

430

779

Asthma-related pneumonia

630

1767

3.63

188.10

1.2

1.0

6.22

2.84

u/ml

3.26

428

775

ILD medications: prednisolone, methylprednisolone, prednisone

2066

5547

2.10

184.84

1.1

5.39

3.61

u/ml

3.49

1212

2625

Childhood asthma (age<16)

552

1127

4.03

173.04

1.1

1.0

10.08

3.02

u/ml

9.99

417

494

Childhood asthma (age<16), excluding more controls

551

1129

4.02

171.85

1.1

1.0

10.10

3.01

u/ml

10.04

416

496

Cough

830

2750

2.88

165.62

1.1

3.19

4.41

u/ml

1.17

461

1347

Diseases of the respiratory system

1017

1846

2.80

162.83

1.1

1.0

3.84

2.46

u/ml

1.89

542

706

Biological medicines for asthma

172

183

11.41

150.37

1.3

1.0

8.14

3.25

u/ml

2.27

135

Abnormalities of breathing

1764

5020

2.04

147.38

1.1

3.80

4.47

u/ml

0.82

979

2480

ILD medications

2059

5839

1.92

144.43

1.1

5.27

3.79

u/ml

2.66

1203

2825

Inflammatory bowel disease treatment related agents

2052

6029

1.91

142.15

1.1

5.38

3.65

u/ml

3.31

1194

2897

FESS (DNB20)

373

895

4.39

141.45

1.2

1.1

2.43

3.35

u/ml

0.69

229

432

Ethmoidectomy

378

924

4.30

139.79

1.2

1.1

2.40

3.29

u/ml

0.68

232

446

Deviated nasal septum

503

1509

3.40

135.98

1.1

1.0

2.83

2.80

u/ml

0.02

268

657

Conjunctivitis (acute, non atopic), including avohilmo

1641

5113

1.96

125.32

1.1

5.58

3.70

u/ml

2.46

868

2403

First line medication for Crohn's disease

1965

5789

1.85

122.09

1.1

5.24

3.76

u/ml

2.50

1142

2791

Chronic diseases of tonsils and adenoids

1276

3896

2.09

117.47

1.1

1.0

4.13

3.56

u/ml

0.59

676

1729

Symptoms and signs involving the circulatory and respiratory systems

1821

5043

1.83

108.11

1.1

3.94

4.47

u/ml

0.56

981

2487

Childhood allergy (age < 16)

653

2134

2.66

104.78

1.1

9.88

3.92

u/ml

8.03

493

1137

Adverse effects, not elsewhere classified

535

1982

2.80

101.29

1.1

6.28

4.39

u/ml

1.36

361

1023

Non-allergic asthma (mode)

291

832

3.54

83.86

1.1

1.0

3.01

2.63

u/ml

0.15

130

346

Non-allergic asthma (mode), excluding more controls

291

835

3.52

83.40

1.1

1.0

3.01

2.63

u/ml

0.14

130

349

Dermatitis due to ingested food

223

528

4.53

82.27

1.2

1.1

12.72

2.66

u/ml

8.07

178

299

Insomnia

1540

6263

1.73

81.68

1.1

3.63

4.08

u/ml

0.48

745

3188

Acute upper respiratory infections

1596

5617

1.72

80.52

1.1

4.43

3.80

u/ml

0.67

852

2756

Urticaria

673

3110

2.21

77.98

1.1

4.49

4.52

u/ml

0.01

414

1577

Acute upper respiratory infections of multiple and unspecified sites

1319

5474

1.78

77.69

1.1

5.23

3.86

u/ml

1.38

718

2683

Sleep disorders

1526

6210

1.71

77.67

1.1

3.76

4.09

u/ml

0.31

743

3173

Urticaria and erythema

744

3634

2.09

74.42

1.1

4.83

4.35

u/ml

0.32

452

1847

Acute sinusitis

1004

4925

1.88

73.53

1.1

3.72

3.79

u/ml

0.04

540

2391

Behavioural syndromes associated with physiological disturbances and physical factors

1551

6351

1.67

71.93

1.1

4.10

4.17

u/ml

0.05

762

3269

Sleep apnoea, including avohilmo

1426

5108

1.70

69.94

1.1

3.78

3.84

u/ml

0.03

707

2507

Asthma mixed form (mode)

120

198

6.32

69.93

1.2

1.0

5.34

3.06

u/ml

0.68

Asthma mixed form (mode), excluding more controls

120

198

6.32

69.92

1.2

1.0

5.34

3.06

u/ml

0.68

Dyspnoea

1306

5510

1.73

69.72

1.1

3.45

4.09

u/ml

0.82

732

2672

Other and unspecified effects of external causes

626

2948

2.17

69.26

1.1

5.78

4.45

u/ml

0.98

401

1528

Bronchitis

1689

6328

1.61

67.37

1.1

5.00

3.74

u/ml

1.63

941

3083

D07AA Corticosteroids, weak (group I)

427

1732

2.55

67.27

1.1

12.82

4.11

u/ml

6.90

321

911

Chronic laryngitis and laryngotracheitis

203

537

3.87

66.93

1.1

1.0

2.62

2.12

u/ml

0.35

100

226

Any reimbursement code in KELA

1258

3640

1.76

65.25

1.1

6.50

2.37

u/ml

7.39

741

1627

Diseases of the eye and adnexa

1469

4467

1.67

63.37

1.1

5.07

4.03

u/ml

0.95

836

2145

1616

5153

1.60

60.36

1.1

4.54

3.65

u/ml

1.08

869

2466

Diseases of the skin and subcutaneous tissue

1445

4471

1.63

58.43

1.1

6.34

2.82

u/ml

6.24

813

2057

Sleep disorders (combined)

1621

5402

1.58

57.54

1.1

3.95

4.17

u/ml

0.19

807

2799

Other acute lower respiratory infections

837

4434

1.82

56.02

1.1

6.53

3.95

u/ml

2.54

527

2295

Migraine

1037

4760

1.72

54.89

1.1

4.53

4.26

u/ml

0.13

517

2416

Early onset COPD, excluding more controls

181

533

3.43

50.66

1.1

1.0

5.59

2.31

u/ml

1.66

117

192

Asthma and opportunity respiratory infection

7.87

50.33

1.2

1.0

3.15

1.24

u/ml

0.51

Pain in joint

932

3312

1.75

50.32

1.1

4.53

4.05

u/ml

0.31

504

1717

Dermatitis

815

4546

1.77

50.27

1.1

4.32

2.64

u/ml

2.26

453

2069

Polypectomy (DHB20)

127

296

4.45

50.11

1.2

1.1

2.66

2.87

u/ml

0.06

141

Bronchiectasis

138

6.22

49.01

1.1

1.0

2.89

2.08

u/ml

0.17

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1510

6399

1.52

47.94

1.1

3.41

4.30

u/ml

1.61

750

3266

Sleep apnoea

1222

4869

1.59

47.09

1.1

3.78

3.69

u/ml

0.06

611

2377

Voice disturbances

384

1736

2.25

47.04

1.1

4.02

3.33

u/ml

0.17

206

813

Other medical care

555

2408

1.95

45.69

1.1

4.93

3.60

u/ml

1.11

366

1167

Dentofacial anomalies [including malocclusion]

1243

6286

1.56

45.50

1.1

4.70

4.17

u/ml

0.31

625

3164

Personal history of allergy to drugs, medicaments and biological substances

7.74

43.99

1.4

1.0

1.59

5.10

u/ml

0.90

Acute bronchitis

575

3019

1.89

43.93

1.1

6.03

3.92

u/ml

1.31

348

1519

Any death

2298

0.24

40.91

1.0

1.1

3.92

3.05

u/ml

0.16

1151

Migraine, single triptan purchase ok & required. ICD-code if available is included

1301

5880

1.51

40.16

1.1

4.65

4.10

u/ml

0.33

644

2995

Triptan medication for migraine, single purchase ok

1301

5880

1.51

40.16

1.1

4.65

4.10

u/ml

0.33

644

2995

Headache

1109

5594

1.54

38.76

1.1

3.84

3.97

u/ml

0.09

550

2834

Recurrent or chronic depression

662

2620

1.77

38.74

1.1

4.76

3.42

u/ml

0.98

338

1294

Symptoms and signs involving speech and voice

416

2099

2.01

38.19

1.1

4.26

3.27

u/ml

0.28

221

995

Other and unspecified dermatitis

659

3837

1.73

38.14

1.1

4.29

2.68

u/ml

1.80

363

1772

Dermatographic urticaria

174

604

3.00

37.74

1.1

4.61

3.19

u/ml

0.53

295

Episodal and paroxysmal disorders

1632

5778

1.44

37.74

1.1

4.70

4.33

u/ml

0.23

833

2991

Other and unspecified urticaria

385

1915

2.05

37.13

1.1

4.53

4.35

u/ml

0.08

239

958

COPD/asthma/ILD related infections

1420

4885

1.47

35.69

1.1

4.66

3.69

u/ml

1.10

751

2348

COPD/asthma related infections

1420

4885

1.47

35.69

1.1

4.66

3.69

u/ml

1.10

751

2348

Special screening examination for infectious and parasitic diseases

560

2311

1.79

34.32

1.1

3.94

4.01

u/ml

0.03

293

1064

Allergic contact dermatitis

242

1039

2.38

33.85

1.1

6.06

2.16

u/ml

2.73

136

462

Exposure to unspecified factor

1470

7113

1.41

32.43

1.1

4.91

4.05

u/ml

0.99

793

3596

Other inflammation of eyelid, including avohilmo

786

4998

1.59

32.42

1.1

4.92

4.23

u/ml

0.48

407

2516

Coxibs

355

902

2.09

31.65

1.1

5.74

4.52

u/ml

0.25

166

503

Gastro-oesophageal reflux disease

860

4702

1.55

31.55

1.1

2.97

3.99

u/ml

0.65

417

2309

Other chronic obstructive pulmonary disease

234

830

2.32

30.39

1.1

1.0

5.45

1.39

u/ml

3.01

146

334

Temporomandibular joint disorders, including avohilmo

840

5347

1.54

29.83

1.1

4.32

4.27

u/ml

0.02

449

2648

COPD

246

892

2.25

29.77

1.1

1.0

5.26

1.45

u/ml

2.87

152

364

Intestinal infectious diseases, including avohilmo, including avohilmo

1554

6274

1.39

29.63

1.1

3.39

4.35

u/ml

1.71

759

3209

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

620

1858

1.69

28.83

1.1

4.18

4.46

u/ml

0.15

320

942

Triptan medication for migraine, min. 3 purchases

1062

5471

1.46

28.66

1.1

4.17

4.19

u/ml

0.01

502

2734

Abnormal findings on diagnostic imaging of lung

373

1890

1.88

28.52

1.1

3.14

3.04

u/ml

0.06

216

900

Atopic conjunctivitis

115

377

3.18

27.74

1.1

5.96

4.13

u/ml

0.56

196

Mycoses, including avohilmo

1303

7141

1.40

27.46

1.1

3.92

4.14

u/ml

0.19

638

3648

Acetic acid derivatives and related substances

329

845

2.03

27.40

1.1

2.90

4.46

u/ml

1.33

162

467

Medical observation and evaluation for suspected diseases and conditions

893

3021

1.52

27.22

1.1

4.72

4.16

u/ml

0.30

519

1401

Abnormalities of heart beat

427

2362

1.77

26.67

1.1

3.83

4.44

u/ml

0.33

227

1152

Irritable bowel syndrome

429

2460

1.77

26.60

1.1

3.39

4.06

u/ml

0.34

207

1220

Idiopathic urticaria

196

4.08

25.90

1.1

2.91

3.78

u/ml

0.21

Eosinophilic disease (BM)

7.91

25.72

1.3

1.0

3.44

1.07

u/ml

0.72

Other special examinations and investigations of persons without complaint or reported diagnosis

889

3021

1.50

25.43

1.1

4.15

4.16

u/ml

0.01

504

1401

Pain and other conditions associated with female genital organs and menstrual cycle

445

2169

1.74

25.43

1.1

2.06

5.18

u/ml

7.76

218

1146

Anxiety disorders

1323

6636

1.38

25.04

1.1

4.13

4.17

u/ml

0.02

723

3277

Neurotic, stress-related and somatoform disorders

1317

6639

1.37

24.82

1.1

4.10

4.18

u/ml

0.05

722

3278

Tonsillectomy and adenotomy

1136

5658

1.41

24.74

1.1

4.34

4.33

u/ml

0.01

616

2911

Pain (limb, back, neck, head abdominally)

984

3406

1.46

24.28

1.1

4.49

4.07

u/ml

0.32

525

1789

Pain in throat and chest

1126

4759

1.41

23.95

1.1

4.39

4.43

u/ml

0.02

558

2322

Malignant neoplasm

555

5049

0.64

22.81

1.1

2.45

3.87

u/ml

1.99

259

2469

Renal tubulo-interstitial diseases

546

6192

0.64

22.55

1.1

5.08

4.22

u/ml

0.52

286

3114

Conjunctivitis (acute, non atopic)

425

2535

1.69

22.54

1.1

8.24

4.33

u/ml

1.61

241

1243

Symptoms and signs involving the digestive system and abdomen

1339

4970

1.36

22.09

1.1

3.72

4.44

u/ml

0.81

709

2562

Diabetes, insulin treatment (Kela reimbursement)

648

5760

0.67

22.03

1.1

2.83

3.95

u/ml

1.55

340

2825

Caries of enamel

1332

6503

1.35

21.99

1.1

3.78

4.20

u/ml

0.43

694

3235

Malignant neoplasm

560

5041

0.65

21.93

1.1

2.44

3.87

u/ml

2.04

262

2464

Abdominal and pelvic pain

1335

4969

1.36

21.93

1.1

3.77

4.44

u/ml

0.74

706

2561

Depression or dysthymia

776

2863

1.49

21.88

1.1

5.50

3.39

u/ml

1.29

391

1434

Diabetes medication

801

6679

0.70

21.31

1.1

3.27

4.07

u/ml

0.85

424

3303

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

629

5567

0.67

21.28

1.1

2.81

3.94

u/ml

1.51

331

2727

Exposure to other specified factors

1157

7345

1.36

21.19

1.1

4.87

4.08

u/ml

0.74

625

3722

Propionic acid derivatives

369

1047

1.79

21.13

1.1

4.38

4.72

u/ml

0.14

193

605

Disorders of lacrimal system

507

3170

1.59

21.04

1.1

5.18

3.85

u/ml

0.79

240

1544

Solid cancers

529

4781

0.64

21.04

1.1

2.52

3.88

u/ml

1.70

244

2311

All kidney diseases

748

7202

0.69

21.01

1.1

4.98

4.11

u/ml

0.64

398

3622

Other headache syndromes

577

3772

1.54

20.89

1.1

3.83

3.88

u/ml

0.02

289

1836

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1248

7267

1.34

20.88

1.1

5.19

4.04

u/ml

1.28

631

3726

Other disorders of lacrimal gland

426

2606

1.65

20.82

1.1

5.10

3.73

u/ml

0.74

199

1261

All anxiety disorders

1066

6055

1.38

20.66

1.1

3.50

4.29

u/ml

0.98

602

3005

Simple and mucopurulent chronic bronchitis

101

4.75

20.60

1.1

2.47

2.18

u/ml

0.07

Codeine

1310

5311

1.34

20.24

1.1

3.96

4.00

u/ml

0.02

672

2636

Migraine with aura

466

2944

1.60

20.08

1.1

4.62

3.93

u/ml

0.28

248

1480

Other specific joint derangements/joint disorders

1173

5425

1.36

20.05

1.1

4.54

4.36

u/ml

0.11

614

2765

Bronchitis, not specified as acute or chronic

357

2.82

20.01

1.1

1.0

6.29

1.51

u/ml

2.07

158

Codeine or tramadol medication

1460

6085

1.31

19.25

1.1

3.80

4.02

u/ml

0.15

735

3000

Malignant neoplasm, wide definition

614

5249

0.68

19.19

1.1

2.56

3.93

u/ml

1.95

290

2584

Malignant neoplasm, including Hilmo

618

5259

0.68

18.80

1.1

2.54

3.96

u/ml

2.08

293

2584

Schizophrenia

1413

0.23

18.80

1.1

5.56

3.43

u/ml

0.38

721

Diabetes, varying definitions

822

6624

0.72

18.72

1.1

3.33

4.04

u/ml

0.70

426

3285

Other viral diseases, including avohilmo

695

4797

1.45

18.71

1.1

5.01

4.61

u/ml

0.15

380

2533

Diseases of the musculoskeletal system and connective tissue

948

3432

1.39

18.57

1.1

5.46

4.34

u/ml

0.64

513

1816

Anxiety disorders, excluding more controls

1151

5516

1.34

18.42

1.1

3.98

3.72

u/ml

0.20

636

2677

Cystitis

1078

4756

1.35

18.33

1.1

4.27

4.20

u/ml

0.04

508

2419

Anti-inflammatory and antirheumatic products, non-steroids

357

1048

1.73

18.29

1.1

4.26

4.71

u/ml

0.20

192

606

Diabetes mellitus

833

6645

0.72

18.27

1.1

3.31

4.05

u/ml

0.78

435

3298

Any event in cancer register

717

5924

0.70

18.23

1.1

3.23

4.03

u/ml

0.73

337

2943

Anxiety (asthma-related co-morbidities)

1024

5779

1.36

18.14

1.1

3.50

4.00

u/ml

0.53

579

2835

Other dorsopathies, not elsewhere classified

1402

5602

1.31

18.05

1.1

4.00

4.17

u/ml

0.10

736

2831

Neurological diseases

1289

4921

1.32

18.00

1.1

4.54

4.49

u/ml

0.02

661

2561

Solid cancers, including Hilmo

592

5032

0.68

17.89

1.1

2.63

3.83

u/ml

1.47

276

2449

Parasetamol

1104

4155

1.35

17.83

1.1

4.60

4.00

u/ml

0.37

587

2125

Diseases of middle ear and mastoid

941

5690

1.36

17.20

1.1

3.99

4.44

u/ml

0.36

526

2933

Other joint disorders

1376

5548

1.30

17.15

1.1

4.56

4.38

u/ml

0.13

724

2834

Migraine with aura and triptan purchases

330

2003

1.67

16.97

1.1

4.60

3.94

u/ml

0.20

178

1019

Persons encountering health services for examination and investigation

838

3021

1.40

16.83

1.1

3.58

4.16

u/ml

0.50

456

1401

Eosinophilia

5.11

16.82

1.3

1.0

3.44

2.37

u/ml

0.25

Opioids

1371

5495

1.29

16.56

1.1

4.16

4.05

u/ml

0.06

705

2752

Myalgia

345

2127

1.64

16.55

1.1

4.50

4.24

u/ml

0.08

176

1058

Candidiasis, including avohilmo

426

2765

1.56

16.40

1.1

3.86

4.30

u/ml

0.20

208

1401

Nonsuppurative otitis media, including avohilmo

605

3639

1.45

16.26

1.1

3.40

4.86

u/ml

1.88

350

1941

COPD (mode)

135

473

2.23

16.23

1.1

1.0

5.02

2.30

u/ml

1.14

182

Insulin medication

296

4032

0.61

16.20

1.1

2.96

4.03

u/ml

1.01

172

2062

Paracetamol or NSAID medication

257

714

1.83

16.10

1.1

5.29

4.70

u/ml

0.19

146

416

Other antidepressants

1258

4951

1.30

15.95

1.1

4.20

3.81

u/ml

0.32

642

2480

Acute bronchiolitis

187

885

1.97

15.84

1.2

1.1

9.98

5.11

u/ml

1.84

143

538

Dorsalgia

1347

5564

1.29

15.82

1.1

4.02

4.06

u/ml

0.02

691

2808

Other soft tissue disorders, not elsewhere classified

1289

5698

1.29

15.72

1.1

4.50

4.33

u/ml

0.11

634

2963

Heartburn

151

736

2.08

15.69

1.1

2.94

2.98

u/ml

0.01

356

Neurological diseases, wide definition

596

2053

1.47

15.64

1.1

5.30

4.18

u/ml

0.41

325

1140

Other bacterial diseases

630

5843

0.71

15.36

1.1

5.61

3.91

u/ml

1.50

344

2935

Schizophrenia or delusion

162

3074

0.52

15.35

1.1

3.31

3.99

u/ml

0.31

1556

Low back pain

1037

5325

1.32

15.30

1.1

3.70

3.98

u/ml

0.14

520

2663

Dorsopathies

1429

5702

1.27

15.30

1.1

4.10

4.22

u/ml

0.07

752

2910

Allergic urticaria

154

766

2.05

15.27

1.2

1.1

5.02

3.82

u/ml

0.39

387

Schizophrenia, schizotypal and delusional disorders

163

3078

0.52

15.20

1.1

3.28

3.98

u/ml

0.33

1560

Biguanides

631

5332

0.71

15.18

1.1

3.30

3.79

u/ml

0.34

322

2539

Fenamates

159

529

2.07

15.15

1.1

3.09

4.13

u/ml

0.31

275

Other (not insulin) diabetes medications

681

5523

0.72

15.10

1.1

3.30

3.73

u/ml

0.31

346

2633

Soft tissue disorders

1435

5809

1.27

15.02

1.1

4.42

4.37

u/ml

0.03

736

3031

Type 2 diabetes

746

5878

0.73

15.00

1.1

3.43

3.83

u/ml

0.31

380

2828

Other chronic obstructive pulmonary disease, including avohilmo

340

1743

1.61

14.93

1.1

5.52

3.01

u/ml

1.75

207

837

Other viral diseases, not elsewhere classified, including avohilmo

478

3226

1.49

14.92

1.1

5.45

4.68

u/ml

0.22

252

1714

Mouth breathing

447

2993

1.50

14.78

1.1

3.45

4.06

u/ml

0.43

253

1542

Selective serotonin reuptake inhibitors

1243

5030

1.29

14.76

1.1

4.58

3.87

u/ml

0.46

621

2540

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

582

3565

1.43

14.54

1.1

3.41

3.57

u/ml

0.10

329

1716

Examination and observation for other reasons

735

3009

1.38

14.39

1.1

3.81

4.16

u/ml

0.24

377

1397

Dermatophytosis, including avohilmo

823

6042

1.34

14.29

1.1

3.74

4.06

u/ml

0.23

400

3043

Hyperkinetic disorders, excluding more controls

359

2164

1.58

14.27

1.1

6.09

4.91

u/ml

0.45

207

1170

Later onset COPD, excluding more controls

111

3.51

14.16

1.0

5.27

1.59

u/ml

0.62

Dysphagia

214

1211

1.78

14.12

1.1

1.0

3.56

3.03

u/ml

0.26

120

577

Haemorrhage from respiratory passages

253

1323

1.70

14.01

1.1

1.0

4.53

3.62

u/ml

0.32

132

634

Type 2 diabetes, strict (exclude DM1)

682

5408

0.73

13.88

1.1

3.35

3.75

u/ml

0.28

342

2576

Depression medications

642

2301

1.42

13.80

1.1

5.85

4.63

u/ml

0.47

341

1170

Certain infectious and parasitic diseases, including avohilmo

915

3456

1.33

13.70

1.1

3.30

4.01

u/ml

0.77

466

1769

Kela-code for severe mental illness

200

3452

0.58

13.64

1.1

2.70

3.93

u/ml

0.91

113

1753

Pruritus

144

729

2.00

13.55

1.1

1.27

1.77

u/ml

0.60

321

Other menopausal disorders

298

1013

1.65

13.50

1.0

1.1

2.99

3.62

u/ml

0.29

143

479

ILD, hospital admissions 1, main diag only

378

2.40

13.45

1.1

2.54

2.09

u/ml

0.18

196

Other inflammation of eyelid

172

927

1.88

13.42

1.1

7.14

3.61

u/ml

1.11

454

Other anxiety disorders

813

5216

1.34

13.40

1.1

3.85

4.28

u/ml

0.33

461

2622

Type 2 diabetes, definitions combined

685

5398

0.73

13.40

1.1

3.33

3.74

u/ml

0.29

344

2571

Diseases of the ear and mastoid process

1550

6277

1.24

13.39

1.1

4.06

4.23

u/ml

0.14

801

3134

Schizophrenia or delusion, excluding more controls

162

2901

0.55

13.25

1.1

3.31

3.44

u/ml

0.05

1450

Early onset COPD

181

994

1.84

13.25

1.1

5.59

3.05

u/ml

1.18

117

471

Disorders of synovium and tendon

668

4163

1.37

13.02

1.1

3.07

3.95

u/ml

0.86

330

2051

Other respiratory diseases principally affecting the interstitium

111

520

2.15

12.81

1.1

2.42

2.84

u/ml

0.18

264

Type 2 diabetes, wide definition

402

3713

0.68

12.69

1.1

2.98

3.29

u/ml

0.19

226

1741

Non-allergic asthma

360

2.39

12.52

1.1

1.0

1.48

1.85

u/ml

0.19

149

Acne, including avohilmo

543

3148

1.41

12.51

1.1

5.15

4.73

u/ml

0.12

277

1738

Disturbance of activity and attention

364

2386

1.51

12.27

1.1

6.00

5.10

u/ml

0.32

215

1351

Suppurative and unspecified otitis media

669

4408

1.35

12.25

1.1

5.14

4.70

u/ml

0.26

384

2342

All chronic kidney diseases

239

3069

0.62

12.18

1.1

6.91

4.11

u/ml

1.15

133

1582

Gastrointestinal diseases

970

3766

1.30

12.07

1.1

5.51

4.55

u/ml

0.53

498

1952

Migraine without aura

395

2701

1.48

12.07

1.1

4.16

4.43

u/ml

0.06

200

1382

Disease of hard tissues of teeth, NOS

553

2060

1.41

12.06

1.1

3.82

3.99

u/ml

0.05

291

953

Herpesviral [herpes simplex] infections, including avohilmo

394

2693

1.48

12.03

1.1

6.29

4.05

u/ml

1.25

198

1338

Insulin, combination of fast acting with intermediate-acting or long-acting

296

4104

0.65

12.01

1.1

2.96

3.97

u/ml

0.93

172

2087

Oxicams

183

571

1.83

12.00

1.0

1.1

0.95

3.71

u/ml

5.01

298

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

100

314

2.25

11.99

1.1

2.56

2.97

u/ml

0.14

157

Type 2 diabetes, definitions combined, including avohilmo

712

5451

0.75

11.97

1.1

3.35

3.74

u/ml

0.27

355

2599

Hyperkinetic disorders

374

2476

1.50

11.95

1.1

5.95

5.02

u/ml

0.35

221

1397

ILD, hospital admissions

431

2.22

11.92

1.1

2.50

2.30

u/ml

0.07

226

Other interstitial pulmonary diseases

432

2.22

11.85

1.1

2.50

2.29

u/ml

0.07

227

Interstitial lung disease endpoints

433

2.21

11.79

1.1

2.50

2.28

u/ml

0.08

228

Interstitial lung disease

433

2.21

11.79

1.1

2.50

2.28

u/ml

0.08

228

Other and unspecified nonorganic psychotic disorders

114

2209

0.51

11.76

1.1

3.53

4.16

u/ml

0.21

1139

Other bacterial diseases, including avohilmo

832

6707

0.77

11.71

1.1

5.66

3.82

u/ml

2.16

458

3362

Depression

1250

6736

1.24

11.70

1.1

5.09

3.78

u/ml

1.11

663

3346

Diseases of oesophagus, stomach and duodenum

1296

6179

1.24

11.67

1.1

3.13

4.09

u/ml

0.95

649

3089

Renal failure

102

1739

0.50

11.42

1.1

4.24

3.49

u/ml

0.26

879

Migraine without aura and triptan purchases

320

2124

1.53

11.40

1.1

4.62

3.93

u/ml

0.13

155

1086

Soft tissue disorders related to use, overuse and pressure

264

1682

1.58

11.19

1.1

3.66

3.28

u/ml

0.13

124

806

Disorders of eyelid, lacrimal system and orbit

966

5577

1.27

11.18

1.1

4.94

3.79

u/ml

1.04

468

2759

Functional dyspepsia

295

1936

1.53

10.98

1.1

3.23

3.53

u/ml

0.14

147

934

Injuries to the ankle and foot

1059

7242

1.25

10.97

1.1

5.21

4.08

u/ml

0.72

568

3664

Arthropathies

1358

5597

1.23

10.93

1.1

4.21

4.40

u/ml

0.14

713

2874

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

324

2175

1.51

10.93

1.1

5.05

4.50

u/ml

0.18

160

1089

Persons encountering health services for specific procedures and health care

1425

6912

1.22

10.89

1.1

4.28

4.17

u/ml

0.08

847

3411

Unspecified mental disorder

266

4059

0.65

10.88

1.1

2.61

4.03

u/ml

1.50

150

2065

Lichen simplex chronicus and prurigo

268

2.50

10.76

1.1

3.44

1.59

u/ml

0.84

118

Inflammatory diseases of female pelvic organs

899

4828

1.28

10.75

1.1

3.71

4.37

u/ml

0.56

437

2349

Cerebrovascular diseases

270

2857

0.65

10.69

1.1

3.50

3.11

u/ml

0.15

120

1382

Visual disturbances

530

3902

1.37

10.58

1.1

4.98

4.15

u/ml

0.28

290

1981

Allergic colitis

407

2.25

10.55

1.1

9.30

6.96

u/ml

0.40

251

Injuries to the wrist and hand

1312

7128

1.22

10.54

1.1

4.76

4.02

u/ml

0.71

700

3614

Subjective visual disturbances

291

1924

1.52

10.50

1.1

3.08

3.65

u/ml

0.33

163

946

Dislocation, sprain and strain of joints and ligaments of knee

866

6167

1.28

10.44

1.1

5.61

3.76

u/ml

1.62

456

3043

Periodontitis

726

5978

0.77

10.35

1.1

4.59

3.63

u/ml

0.59

379

2893

Malignant neoplasm of breast

220

2235

0.63

10.13

1.0

1.1

2.94

3.35

u/ml

0.24

1003

Other diseases of lip and oral mucosa

461

3344

1.39

10.13

1.1

3.75

4.13

u/ml

0.20

252

1643

Peritonsillar abscess

239

1526

1.58

10.12

1.1

1.0

3.53

3.63

u/ml

0.04

123

687

Restless leg syndrome

158

908

1.76

10.10

1.1

3.57

3.19

u/ml

0.11

444

Chronic periodontitis, including avohilmo

727

5965

0.77

10.01

1.1

4.55

3.64

u/ml

0.54

379

2885

Malignant neoplasm of breast, HER2-negative

221

2234

0.63

9.95

1.0

1.1

2.92

3.34

u/ml

0.25

1003

Excessive attrition of teeth

840

6576

1.27

9.93

1.1

2.87

4.33

u/ml

3.26

448

3275

Infective dermatitis

112

582

1.94

9.90

1.1

4.88

1.85

u/ml

1.71

260

Vocal cord dysfunction

196

1052

1.66

9.87

1.2

1.1

5.51

3.93

u/ml

0.22

108

486

Transport accidents

632

4003

1.32

9.86

1.1

4.51

3.72

u/ml

0.40

329

1975

Acute suppurative otitis media

535

3720

1.35

9.85

1.1

5.06

4.83

u/ml

0.11

310

2000

Accidents

1043

4195

1.25

9.76

1.1

5.60

3.66

u/ml

1.51

541

2065

Visual disturbances and blindness

550

4126

1.34

9.66

1.1

4.97

4.13

u/ml

0.30

304

2106

Insulin, intermediate and long-acting

261

3756

0.67

9.55

1.1

3.17

3.99

u/ml

0.59

152

1907

Enthesopathies of lower limb, excluding foot

268

1784

1.51

9.43

1.1

3.12

3.41

u/ml

0.15

136

839

ILD, hospital admission 2, with pulmonary infections

230

2.50

9.42

1.1

2.90

1.86

u/ml

0.33

102

Malignant neoplasm of breast, including Hilmo

235

2299

0.65

9.40

1.0

1.1

2.96

3.46

u/ml

0.31

106

1027

1034

4885

1.24

9.36

1.1

4.81

3.69

u/ml

1.06

597

2348

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1034

4885

1.24

9.36

1.1

4.81

3.69

u/ml

1.06

597

2348

Lower back pain or/and sciatica

1313

6765

1.21

9.36

1.1

3.91

3.96

u/ml

0.03

659

3373

Internal derangement of knee

420

3013

1.39

9.31

1.1

3.14

4.09

u/ml

0.67

211

1463

COPD, hospital admissions

232

1255

1.56

9.30

1.1

1.0

5.45

2.73

u/ml

1.51

144

588

Emphysema

109

3.23

9.30

1.2

1.0

1.24

1.29

u/ml

0.03

COPD, early/later onset

234

1265

1.56

9.26

1.1

1.0

5.45

2.72

u/ml

1.56

146

594

Malignant neoplasm of breast, HER2-negative, including Hilmo

236

2299

0.65

9.25

1.0

1.1

2.94

3.46

u/ml

0.32

107

1027

Other contact dermatitis

500

1.99

9.20

1.2

1.1

6.86

1.89

u/ml

1.53

220

Alcohol dependence

1705

0.51

9.13

1.1

3.45

3.13

u/ml

0.08

836

Dermatitis due to substances taken internally

330

2.22

9.00

1.1

8.18

1.75

u/ml

2.03

150

Vasomotor rhinitis (mode)

410

2.08

8.93

1.1

2.44

3.20

u/ml

0.27

205

Acute tubulo-interstitial nephritis

395

4572

0.73

8.92

1.1

4.32

4.30

u/ml

0.01

201

2323

Excessive, frequent and irregular menstruation

560

2250

1.34

8.89

1.1

3.89

5.04

u/ml

0.89

288

1195

Stroke, including SAH

188

2131

0.63

8.87

1.1

3.74

2.91

u/ml

0.28

1048

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

940

0.37

8.83

1.0

1.1

1.00

2.92

u/ml

3.33

445

Other external causes of accidental injury

1032

4195

1.24

8.83

1.1

5.67

3.66

u/ml

1.58

537

2065

Mental and behavioural disorders due to alcohol, excluding acute intoxication

225

3368

0.66

8.83

1.1

4.36

3.74

u/ml

0.25

136

1683

Cervicocranial syndrome

123

685

1.81

8.82

1.1

1.97

3.36

u/ml

1.06

333

Mood [affective] disorders

1269

6763

1.20

8.78

1.1

5.08

3.79

u/ml

1.09

669

3364

Female infertility, cervical, vaginal, other or unspecified origin

405

1868

1.40

8.75

1.1

5.29

4.84

u/ml

0.10

200

956

Acute pharyngitis

276

1865

1.48

8.68

1.1

3.27

4.58

u/ml

0.97

135

994

Alcohol use disorder, ICD-based

206

3156

0.65

8.67

1.1

4.22

3.80

u/ml

0.15

124

1576

Mood disorders

1269

6762

1.20

8.64

1.1

5.07

3.80

u/ml

1.08

670

3362

Unspecified chronic bronchitis

3.98

8.61

1.2

1.0

9.22

0.71

u/ml

0.61

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

429

3166

1.36

8.59

1.1

3.73

4.12

u/ml

0.23

237

1623

Other and unspecified tonsillitis

586

3750

1.31

8.54

1.1

4.53

4.07

u/ml

0.25

319

1941

Oesophagitis

224

2.44

8.50

1.1

1.0

1.58

2.25

u/ml

0.44

110

Follow-up examination after treatment for conditions other than malignant neoplasms

506

2530

1.34

8.47

1.1

5.09

4.08

u/ml

0.51

253

1148

Malignant neoplasm of digestive organs, including Hilmo

110

1435

0.56

8.35

1.1

3.70

3.05

u/ml

0.22

707

Organic, including symptomatic, mental disorders

1198

0.53

8.28

1.0

1.1

2.21

2.71

u/ml

0.18

589

COPD, hospital admissions 1, only main diagnosis

161

839

1.65

8.27

1.1

4.45

2.80

u/ml

0.70

101

413

Endometriosis of pelvic peritoneum

229

1378

1.53

8.27

1.1

1.23

4.50

u/ml

6.89

110

695

Viral warts, including avohilmo

335

2392

1.41

8.26

1.1

4.14

4.67

u/ml

0.20

152

1277

Substance abuse

386

4864

0.73

8.22

1.1

6.27

3.66

u/ml

1.80

235

2436

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

521

3469

1.32

8.22

1.1

5.32

5.05

u/ml

0.12

293

1937

389

4584

0.73

8.19

1.1

4.83

3.73

u/ml

0.68

229

2281

Female infertility

438

1938

1.36

8.14

1.1

5.68

5.11

u/ml

0.13

214

1000

Somatoform disorder

216

1421

1.53

8.14

1.1

2.10

4.01

u/ml

2.02

110

679

Acute laryngitis and tracheitis

241

1599

1.50

8.13

1.1

5.79

4.93

u/ml

0.28

147

879

Symptoms and signs involving the skin and subcutaneous tissue

817

6228

1.24

8.10

1.1

4.05

u/ml

0.00

433

3082

Fibromyalgia

137

810

1.71

8.06

1.1

2.74

3.44

u/ml

0.39

376

Other diseases of oesophagus

372

2.06

8.02

1.1

2.66

2.76

u/ml

0.03

191

Heart failure, not strict

332

3098

0.72

7.98

1.1

4.08

3.46

u/ml

0.36

184

1516

Other diseases of intestines

1435

6774

1.18

7.97

1.1

3.68

4.42

u/ml

0.90

700

3513

Inflammatory diseases of prostate (prostatitis)

497

1.91

7.97

1.1

0.76

3.68

u/ml

4.00

267

Psychiatric diseases

1143

4746

1.21

7.96

1.1

5.01

3.90

u/ml

0.80

603

2379

Disorders of skin appendages

694

5493

1.26

7.96

1.1

5.19

4.10

u/ml

0.50

369

2814

Mental and behavioural disorders due to psychoactive substance use

407

4991

0.74

7.95

1.1

6.39

3.67

u/ml

1.96

241

2506

Seborrhoeic dermatitis

512

1.89

7.95

1.1

1.0

2.49

1.50

u/ml

0.61

242

Exfoliative dermatitis

6.31

7.94

1.1

24.72

1.21

u/ml

2.02

Irregular menses

782

4720

1.25

7.94

1.1

3.20

4.52

u/ml

1.63

375

2288

Generalized anxiety disorder

319

2277

1.41

7.88

1.1

4.30

4.82

u/ml

0.21

184

1163

Nummular dermatitis

335

2.11

7.86

1.1

4.47

1.70

u/ml

0.65

148

359

4364

0.73

7.84

1.1

4.93

3.75

u/ml

0.70

214

2194

Intestinal infectious diseases

1172

7296

1.20

7.81

1.1

4.12

4.26

u/ml

0.09

632

3709

External causes of morbidity and mortality

877

3558

1.24

7.76

1.1

6.04

3.52

u/ml

1.79

446

1774

Codes for special purposes

624

4875

1.27

7.74

1.1

3.38

4.28

u/ml

0.87

353

2488

Dipeptidyl peptidase 4 (DPP-4) inhibitors

168

2059

0.64

7.69

1.0

1.1

1.60

2.81

u/ml

2.20

998

Mood disorders, excluding more controls

1128

5522

1.20

7.69

1.1

5.17

3.63

u/ml

1.26

603

2677

Other diseases of hard tissues of teeth

530

2092

1.32

7.68

1.1

2.79

4.10

u/ml

1.48

274

978

Provisional assignment of new diseases of uncertain etiology

623

4873

1.27

7.67

1.1

3.38

4.28

u/ml

0.87

353

2487

Injuries to the knee and lower leg

1488

6860

1.18

7.62

1.1

4.72

4.01

u/ml

0.68

770

3471

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

110

622

1.79

7.59

1.1

7.98

3.87

u/ml

0.96

308

Other nutritional deficiencies

859

6419

1.23

7.53

1.1

4.52

4.00

u/ml

0.30

455

3164

Stroke, excluding SAH

168

1888

0.64

7.52

1.1

3.84

2.98

u/ml

0.27

922

Cervicalgia

205

1358

1.52

7.49

1.1

3.06

3.47

u/ml

0.14

100

633

Adenomyosis (Endometriosis of uterus)

134

802

1.68

7.47

1.1

3.12

4.16

u/ml

0.33

380

Trochanteric bursitis

131

784

1.68

7.35

1.1

3.06

2.93

u/ml

0.03

366

Diaphragmatic hernia

240

1648

1.46

7.32

1.1

1.83

3.22

u/ml

1.54

130

778

Substance abuse, excluding more controls

386

4300

0.75

7.31

1.1

6.27

3.57

u/ml

1.91

235

2111

COPD related to multimorbidity

171

920

1.58

7.25

1.1

1.0

6.16

2.33

u/ml

1.74

105

433

Mental and behavioural disorders due to alcohol

313

4087

0.73

7.23

1.1

5.28

3.70

u/ml

0.91

185

2045

Spondylolisthesis/Spondylolysis

163

1035

1.59

7.22

1.0

2.72

3.05

u/ml

0.15

485

Other general symptoms and signs

100

555

1.82

7.19

1.2

1.1

1.74

5.63

u/ml

3.59

308

Alcohol use disorder, Swedish definition

317

3939

0.73

7.17

1.1

4.23

3.68

u/ml

0.28

188

1945

Disturbances of skin sensation

359

2669

1.35

6.96

1.1

3.13

4.05

u/ml

0.55

187

1305

Diseases of external ear

367

2738

1.35

6.93

1.1

3.77

4.56

u/ml

0.44

193

1407

Other enthesopathies

317

2312

1.38

6.91

1.1

2.53

3.68

u/ml

0.78

148

1091

COPD, hospital admission 2, with asthma infections

152

821

1.60

6.90

1.1

4.81

2.78

u/ml

0.89

400

Diseases of appendix

885

6553

1.21

6.88

1.1

3.67

3.88

u/ml

0.14

427

3216

Other noninfective gastroenteritis and colitis

287

2061

1.40

6.87

1.1

5.10

4.70

u/ml

0.13

162

1111

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

175

1129

1.55

6.85

1.2

1.1

4.72

4.88

u/ml

0.04

643

Ganglion

265

1881

1.42

6.84

1.1

3.94

4.12

u/ml

0.05

139

915

STROKE

302

2784

0.73

6.76

1.0

1.1

3.49

3.41

u/ml

0.03

151

1310

Acute appendicitis, no complications

713

5766

1.23

6.75

1.1

3.20

3.86

u/ml

0.59

342

2836

Tinnitus

213

1455

1.47

6.74

1.1

2.40

3.56

u/ml

0.81

103

701

Appendicitis, broad definition

879

6543

1.21

6.73

1.1

3.55

3.88

u/ml

0.25

424

3209

Other extrapyramidal and movement disorders in other diseases

207

1410

1.48

6.65

1.1

4.05

3.40

u/ml

0.20

686

Diseases of salivary glands

351

2621

1.35

6.62

1.1

2.54

4.09

u/ml

1.58

176

1290

Rosacea

153

981

1.57

6.58

1.1

5.56

3.92

u/ml

0.57

461

General symptoms and signs

1366

5867

1.17

6.56

1.1

4.56

4.02

u/ml

0.38

703

2980

Otitis externa

270

1941

1.40

6.50

1.1

3.29

4.19

u/ml

0.50

139

988

Hypertrophy of breast in women and men

246

1744

1.42

6.43

1.1

5.08

3.63

u/ml

0.30

115

825

Ovarian cyst

456

2008

1.31

6.40

1.1

2.90

4.97

u/ml

2.12

237

1041

Other degenerative diseases of the nervous system

1043

0.56

6.38

1.0

1.1

1.09

2.81

u/ml

2.53

487

Other disorders of adrenal gland

337

1.99

6.36

1.2

1.1

1.47

5.30

u/ml

3.32

184

Pain in limb

1028

5505

1.19

6.35

1.1

4.25

4.34

u/ml

0.05

506

2854

Erysipelas, including avohilmo

443

4212

0.78

6.30

1.1

5.95

3.35

u/ml

2.27

255

2055

Noninflammatory disorders of female genital tract

572

2274

1.27

6.27

1.1

5.54

5.17

u/ml

0.10

281

1212

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

747

4769

1.22

6.24

1.1

4.08

4.00

u/ml

0.04

340

2282

Peripheral artery disease

998

0.54

6.22

1.1

2.10

2.46

u/ml

0.10

486

Malignant neoplasm of breast, ER-positive, including Hilmo

149

1692

0.65

6.22

1.1

1.89

3.30

u/ml

1.64

754

Panic disorder

263

1900

1.40

6.22

1.1

4.64

4.45

u/ml

0.06

160

956

Unspecified privation

119

730

1.65

6.18

1.1

3.36

3.51

u/ml

0.05

369

Acute appendicitis

834

6451

1.20

6.15

1.1

3.48

3.85

u/ml

0.28

404

3167

Ischaemic Stroke, excluding all haemorrhages

150

1681

0.65

6.15

1.1

3.75

2.86

u/ml

0.26

820

Chronic gastritis

149

964

1.55

6.13

1.1

2.48

3.53

u/ml

0.53

452

Schizoaffective disorder

704

0.39

6.11

1.1

3.20

3.46

u/ml

0.05

356

Malignant neoplasm of breast, HER-positive

149

1687

0.65

6.11

1.1

1.89

3.28

u/ml

1.61

751

Occupational exposure to risk-factors

158

2.45

6.07

1.2

1.1

2.91

2.76

u/ml

0.03

Unspecified acute lower respiratory infection

167

1114

1.51

6.02

1.1

6.25

3.21

u/ml

1.71

103

558

Malignant neoplasm of digestive organs

1258

0.60

6.01

1.1

4.01

3.09

u/ml

0.29

629

Ocular pain

117

721

1.64

6.00

1.1

3.83

3.93

u/ml

0.02

363

Other diseases of urinary system

1126

5386

1.18

6.00

1.1

3.84

4.06

u/ml

0.17

552

2757

Infections with a predominantly sexual mode of transmission, including avohilmo

691

5196

1.22

5.97

1.1

4.66

4.42

u/ml

0.12

350

2671

Otalgia

118

730

1.64

5.96

1.2

1.1

3.84

4.91

u/ml

0.32

395

Other diseases of the respiratory system

118

728

1.63

5.96

1.1

4.45

3.57

u/ml

0.29

373

Other respiratory disorders and diseases

118

728

1.63

5.96

1.1

4.45

3.57

u/ml

0.29

373

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1326

6081

1.16

5.94

1.1

4.49

3.96

u/ml

0.39

739

3023

Sub-endpoint used in defining T1D endpoints

180

2566

0.69

5.90

1.1

3.17

4.29

u/ml

0.77

104

1368

Drug-induced adrenocortical insufficiency

113

2.73

5.90

1.2

1.0

1.39

3.84

u/ml

0.66

Autoimmune diseases excluding thyroid diseases, strict definition

989

6337

0.85

5.88

1.1

3.54

4.51

u/ml

1.25

515

3285

GASTRO-related operations

1159

4969

1.17

5.87

1.1

4.45

4.49

u/ml

0.02

592

2596

Any gastric operation

1159

4969

1.17

5.87

1.1

4.45

4.49

u/ml

0.02

592

2596

Autoimmune diseases excluding thyroid diseases

1012

6448

0.85

5.87

1.1

3.48

4.48

u/ml

1.34

526

3329

ILD, hospital admissions 3, with pneumonia sepsis

198

2.24

5.85

1.1

1.78

2.23

u/ml

0.19

Oedema, not elsewhere classified

279

2005

1.36

5.82

1.1

2.99

3.61

u/ml

0.41

149

993

Dislocation, sprain and strain of joints and ligaments at neck level

237

1705

1.40

5.77

1.1

3.08

4.53

u/ml

1.05

128

861

Cervical disc disorders

284

2103

1.36

5.72

1.1

3.82

3.14

u/ml

0.33

143

956

Disorders of tooth development and eruption

233

1355

1.41

5.71

1.1

5.77

4.91

u/ml

0.11

112

665

Deforming dorsopathies

293

2182

1.35

5.68

1.0

1.1

4.02

4.29

u/ml

0.12

149

1075

Pain in thoracic spine

175

1194

1.48

5.68

1.1

4.08

3.66

u/ml

0.13

570

Chondrocostal junction syndrome [Tietze]

235

2.12

5.63

1.0

1.1

5.20

5.65

u/ml

0.06

112

Xerosis cutis

3.46

5.62

1.1

1.0

2.47

2.87

u/ml

0.06

Acute renal failure

821

0.46

5.62

1.0

1.1

2.86

3.05

u/ml

0.06

416

Urinary track infection

861

3612

1.20

5.59

1.1

3.73

4.31

u/ml

0.49

418

1797

Lichen simplex chronicus

152

2.40

5.58

1.1

3.24

1.75

u/ml

0.28

Valvular heart disease excluding rheumatic fever

184

1884

0.69

5.56

1.1

4.14

3.91

u/ml

0.07

953

Prurigo nodularis

3.04

5.56

1.0

3.98

1.70

u/ml

0.79

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

706

0.42

5.56

1.1

2.01

2.56

u/ml

—

329

Other viral diseases

445

3509

1.27

5.55

1.1

4.76

4.82

u/ml

0.02

249

1887

Type 1 diabetes

180

2569

0.70

5.52

1.1

3.17

4.40

u/ml

0.87

104

1356

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

927

6883

0.85

5.50

1.1

2.92

4.34

u/ml

2.72

478

3478

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

907

7021

1.18

5.44

1.1

5.72

4.09

u/ml

1.10

488

3560

Heart failure, strict

140

1463

0.66

5.43

1.1

4.17

2.81

u/ml

0.51

733

Cerebrovascular diseases (FINNGEN)

188

1872

0.70

5.42

1.1

4.00

3.76

u/ml

0.06

869

Recurrent aphthous stomatitis , including avohilmo

169

1159

1.47

5.37

1.1

3.55

4.21

u/ml

0.21

608

Hypertrophy of breast

222

1602

1.40

5.34

1.1

5.20

3.80

u/ml

0.25

100

746

4.77

5.31

1.2

1.0

1.28

2.43

u/ml

—

Acute and transient psychotic disorders

999

0.53

5.29

1.1

4.07

3.94

u/ml

0.03

498

Non-invasive ventilation

300

1956

1.33

5.24

1.1

3.23

4.13

u/ml

0.53

188

947

All-cause Heart Failure

137

1427

0.67

5.23

1.1

4.17

2.81

u/ml

0.51

717

Liquid cancers, including Hilmo

122

1639

0.65

5.19

1.1

2.81

3.70

u/ml

0.25

836

Spinal osteochondrosis

3.18

5.13

1.1

2.14

1.45

u/ml

0.18

Condition for Implicit Sepsis (Organ dysfunction codes)

651

5419

0.83

5.10

1.1

4.39

3.99

u/ml

0.23

351

2725

Blepharochalasis

158

1080

1.47

5.09

1.1

4.18

2.31

u/ml

0.64

499

Anomalies of dental arch relationship, including avohilmo

334

2331

1.31

5.09

1.1

7.57

4.69

u/ml

0.73

183

1276

General examination and investigation of persons without complaint and reported diagnosis

701

3021

1.21

5.07

1.1

3.90

4.16

u/ml

0.14

394

1401

Disorders of the thyroid gland

1069

5982

1.16

5.06

1.1

2.87

4.30

u/ml

2.84

509

3016

Diseases of oral cavity, salivary glands and jaws

506

2093

1.25

5.04

1.1

2.78

4.10

u/ml

1.44

261

978

Other otitis externa (chronic)

454

1.74

5.03

1.1

1.89

4.01

u/ml

1.53

232

Chronic kidney disease

1134

0.57

5.03

1.1

4.44

3.64

u/ml

0.18

582

Any dementia

509

0.46

5.00

1.0

1.1

0.14

1.78

u/ml

5.27

259

Menorrhagia

379

1645

1.29

4.99

1.1

2.73

4.30

u/ml

1.52

187

826

Selective deficiency of immunoglobulin G [IgG] subclasses

4.76

4.95

1.1

12.76

7.37

u/ml

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

508

4124

1.23

4.93

1.1

5.22

3.71

u/ml

0.47

273

1987

Other and unspecified drugs and medicaments

555

1.66

4.93

1.1

6.47

4.14

u/ml

0.40

274

Noninfective enteritis and colitis

533

4358

1.23

4.92

1.1

4.34

u/ml

0.00

279

2269

Non-rheumatic valve diseases

182

1821

0.71

4.89

1.1

4.17

3.76

u/ml

0.13

910

Any dementia, excluding more controls

501

0.46

4.89

1.0

1.1

0.14

1.76

u/ml

5.03

250

Other disorders of urethra and urinary system

753

4412

1.19

4.88

1.1

4.42

4.01

u/ml

0.25

372

2210

Injury, poisoning and certain other consequences of external causes

707

2956

1.20

4.86

1.1

4.74

3.30

u/ml

1.25

354

1473

Other intervertebral disc disorders

871

4422

1.18

4.84

1.1

3.44

3.58

u/ml

0.09

439

2145

Iron deficiency

417

1.77

4.81

1.1

1.40

5.47

u/ml

3.69

203

Nonsuppurative otitis media

407

2812

1.26

4.81

1.1

3.15

5.14

u/ml

2.58

249

1542

Persons encountering health services in other circumstances, wide

1347

6081

1.14

4.80

1.1

4.64

3.96

u/ml

0.52

715

3023

Endometriosis

410

1886

1.27

4.79

1.1

2.56

4.96

u/ml

2.71

205

967

Heart failure,strict

139

1421

0.68

4.78

1.1

4.22

3.07

u/ml

0.40

708

Dyshidrosis [pompholyx]

120

2.48

4.78

1.1

1.0

3.94

2.40

u/ml

0.36

Septicaemia

174

2219

0.71

4.72

1.1

6.30

3.83

u/ml

0.85

1140

Viral and other specified intestinal infections, including avohilmo

481

3769

1.23

4.71

1.1

5.39

5.12

u/ml

0.09

266

2060

Sulfonylureas

601

0.49

4.69

1.0

1.1

4.14

2.27

u/ml

0.39

290

Appendectomy

792

6424

1.18

4.68

1.1

4.06

3.85

u/ml

0.13

385

3162

Dementia, including avohilmo

687

0.55

4.66

1.0

1.1

2.24

2.19

u/ml

0.01

347

Other disorders of patella

213

1565

1.37

4.64

1.1

3.08

3.83

u/ml

0.28

104

746

Hypothyroidism, other/unspecified

995

5655

1.16

4.64

1.1

2.84

4.32

u/ml

2.80

472

2836

Insulin, fast-acting

218

2928

0.74

4.63

1.1

2.80

4.08

u/ml

1.22

126

1523

Other disorders of bone

233

1738

1.35

4.61

1.1

3.21

3.78

u/ml

0.29

122

865

Adrenocortical insufficiency

234

2.00

4.58

1.2

1.1

1.33

3.44

u/ml

1.35

119

Postviral fatigue syndrome

105

2.60

4.58

1.2

1.0

0.55

3.58

u/ml

1.83

Insulin, fast-acting or short human

218

2922

0.74

4.57

1.1

2.80

4.10

u/ml

1.25

126

1525

Striking against or struck by other objects

451

3656

1.24

4.56

1.1

5.79

4.41

u/ml

0.52

233

1986

Degenerative diseases of the nervous system

461

0.45

4.56

1.0

1.1

0.43

1.97

u/ml

2.50

234

Factors influencing health status and contact with health services

320

1235

1.30

4.56

1.1

3.00

4.07

u/ml

0.79

177

542

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

805

0.52

4.52

1.1

13.05

3.67

u/ml

1.06

409

Other and unspecified rosacea

100

639

1.58

4.52

1.1

5.91

3.37

u/ml

0.69

298

Other disorders of eye and adnexa

174

1243

1.41

4.51

1.1

6.00

4.37

u/ml

0.44

626

Superficial injury of lower leg

315

2459

1.29

4.48

1.1

5.57

4.23

u/ml

0.45

161

1248

Diseases of arteries, arterioles and capillaries

260

2497

0.76

4.48

1.1

4.17

2.92

u/ml

0.47

128

1219

COPD-related respiratory insufficiency

256

1.92

4.48

1.1

3.94

1.91

u/ml

0.67

127

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

279

1.90

4.45

1.1

5.81

5.04

u/ml

0.08

149

Other and unspecified vaccines and biological substances

3.24

4.45

1.2

1.1

14.03

4.61

u/ml

0.74

Dialysis, with operation codes

683

0.48

4.44

1.0

1.1

1.31

3.67

u/ml

2.37

369

Diarrhoea and gastroenteritis of presumed infectious origin

862

6629

1.16

4.43

1.1

3.28

4.30

u/ml

1.61

467

3391

Diseases of male genital organs

477

1947

1.24

4.41

1.1

2.93

4.05

u/ml

1.06

251

1121

Hypermobility syndrome

637

1.58

4.40

1.2

1.1

1.41

4.11

u/ml

3.33

303

Dysplasia of cervi uteri

321

1764

1.29

4.34

1.1

4.41

4.95

u/ml

0.17

146

889

Fissure and fistula of anal and rectal regions

230

1729

1.34

4.33

1.1

3.52

3.56

u/ml

0.02

856

Chondropathies

182

1321

1.39

4.32

1.1

3.28

3.79

u/ml

0.21

651

Presence of cardiac and vascular implants and grafts

100

1123

0.65

4.31

1.1

2.54

2.84

u/ml

0.10

569

Allergic contact dermatitis due to drugs in contact with skin

120

2.38

4.29

1.1

1.0

10.85

2.68

u/ml

0.87

Polyp of the female genital tract

285

1237

1.31

4.29

1.1

1.85

3.80

u/ml

2.38

137

606

Extrapyramidal and movement disorders

262

2009

1.31

4.27

1.1

3.69

3.35

u/ml

0.12

126

978

Polyarthropathies

542

4180

0.83

4.26

1.1

4.52

4.13

u/ml

0.19

268

2059

Other arthrosis

446

2427

1.23

4.26

1.1

2.61

3.25

u/ml

0.53

232

1103

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

600

4981

1.19

4.25

1.1

5.40

4.35

u/ml

0.40

313

2596

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

654

3476

1.19

4.23

1.1

4.44

4.59

u/ml

0.06

349

1697

Other septicaemia, including avohilmo

151

1988

0.71

4.23

1.1

7.00

3.77

u/ml

1.05

1020

Nonorganic sleeping disorders, excluding more controls

295

2304

1.29

4.22

1.1

3.57

4.00

u/ml

0.17

149

1155

Other bacterial intestinal infections, including avohilmo

207

1538

1.35

4.22

1.1

4.08

4.37

u/ml

0.05

108

761

Malaise and fatigue

505

3281

1.21

4.22

1.1

2.61

3.95

u/ml

1.95

268

1688

Transplanted organ and tissue status

722

0.51

4.22

1.0

1.1

1.67

5.02

u/ml

3.04

397

Abnormal findings in secretions and smears from cervix uteri vagina vulva

704

4407

1.18

4.20

1.1

4.11

4.17

u/ml

0.03

324

2094

Type 1 diabetes, wide definition, subgroup 1

163

2248

0.72

4.20

1.1

3.36

4.39

u/ml

0.63

1200

Bleeding

520

4384

0.83

4.20

1.1

4.87

3.84

u/ml

0.63

266

2212

Genitourinary diseases

733

3122

1.18

4.18

1.1

4.02

4.78

u/ml

0.62

381

1763

Type 1 diabetes, wide definition

169

2316

0.72

4.18

1.1

3.85

4.46

u/ml

0.28

102

1234

Hypothyroidism, strict autoimmune

857

4853

1.16

4.16

1.1

2.94

4.37

u/ml

2.23

406

2433

Unspecific neurodegenerative disorder

488

0.50

4.15

1.0

1.1

0.76

1.74

u/ml

0.73

247

Other disorders of white blood cells

271

1.86

4.15

1.2

1.1

6.66

3.50

u/ml

0.37

137

Hypothyreosis and Thyroxine purchase for inclusion criteria

1019

5834

1.15

4.12

1.1

2.82

4.25

u/ml

2.72

476

2920

Other spirochaetal diseases, including avohilmo

314

2478

1.27

4.12

1.1

3.58

3.98

u/ml

0.16

143

1222

Disorders of other endocrine glands

495

4038

1.21

4.10

1.1

4.13

4.69

u/ml

0.32

263

2104

Use of disulfiram, acamprosate or naltrexone

675

0.50

4.10

1.1

2.53

3.00

u/ml

0.19

331

Keratitis

375

3023

1.25

4.10

1.1

8.33

3.85

u/ml

1.63

193

1497

Any operation in hilmo

200

1.76

4.09

1.0

1.1

2.66

3.94

u/ml

0.42

101

Deep bite

206

1350

1.35

4.08

1.2

1.1

7.16

5.43

u/ml

0.43

120

792

Disorders of choroid and retina

453

3850

0.82

4.06

1.1

2.67

3.47

u/ml

0.86

230

1873

Disorders of sclera, cornea, iris and ciliary body

571

4802

1.19

4.06

1.1

6.33

3.63

u/ml

1.39

297

2421

Oxycodone

135

1639

0.70

4.05

1.1

2.25

3.22

u/ml

0.81

793

L04AD Calcineurin inhibitors

930

0.58

4.04

1.0

1.1

9.64

4.37

u/ml

0.66

501

Other symptoms and signs involving the nervous and musculoskeletal systems

431

3531

1.22

4.04

1.1

4.24

4.38

u/ml

0.07

247

1774

Crowding of teeth, including avohilmo

222

1390

1.34

4.03

1.1

5.73

5.67

u/ml

0.02

157

806

Trigger finger

132

917

1.45

4.03

1.1

2.87

3.05

u/ml

0.06

432

Persons encountering health services in circumstances related to reproduction

774

4458

1.17

4.03

1.1

4.67

4.46

u/ml

0.12

397

2326

Other disorders of eyelid

249

1803

1.31

4.01

1.1

3.92

2.89

u/ml

0.50

110

861

Other spirochaetal diseases

307

2425

1.27

4.01

1.1

3.68

4.03

u/ml

0.13

138

1195

Other symptoms and signs involving the circulatory and respiratory systems

340

1.75

4.00

1.1

1.0

2.00

3.91

u/ml

0.98

162

Other septicaemia

147

1933

0.71

4.00

1.1

6.75

3.77

u/ml

0.92

992

Benign neoplasm: Ascending colon

438

1.65

3.99

1.1

1.16

2.36

u/ml

1.29

212

Certain infectious and parasitic diseases

1232

5461

1.13

3.98

1.1

4.48

4.11

u/ml

0.30

644

2764

Embedded and impacted teeth

541

3680

1.20

3.96

1.1

4.68

4.72

u/ml

0.01

308

1989

Persons encountering health services in other circumstances

491

4041

1.21

3.95

1.1

4.71

4.24

u/ml

0.24

241

2076

Postmenopausal atrophic vaginitis

167

651

1.40

3.92

1.1

3.13

4.04

u/ml

0.25

288

Metabolic disorders

794

5504

0.86

3.91

1.1

3.34

4.02

u/ml

0.73

437

2686

Stomatitis and related lesions

232

1776

1.31

3.90

1.1

4.95

4.15

u/ml

0.27

121

910

Explicit Sepsis

220

2617

0.76

3.86

1.1

6.00

4.17

u/ml

0.63

126

1335

Dental pulpitis, including avohilmo

1204

6846

1.13

3.85

1.1

4.53

4.00

u/ml

0.40

625

3412

Other neurological diseases

388

3681

0.82

3.83

1.1

3.28

3.93

u/ml

0.38

218

1801

Benign neoplasm: Colon, unspecified

124

860

1.45

3.82

1.1

2.85

2.64

u/ml

0.07

412

Bacterial pneumonia (organism specified)

336

2440

1.25

3.81

1.1

4.67

4.05

u/ml

0.19

205

1214

150

966

1.40

3.80

1.1

2.34

2.20

u/ml

0.06

467

Substance use, excluding alcohol

143

1980

0.72

3.79

1.1

9.74

3.58

u/ml

1.90

1000

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

799

6206

0.87

3.79

1.1

4.95

4.02

u/ml

0.55

413

3136

All influenza

254

1975

1.29

3.79

1.1

5.21

4.20

u/ml

0.41

144

1044

Certain disorders involving the immune mechanism

179

1326

1.36

3.78

1.1

3.85

3.96

u/ml

0.03

657

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

858

6618

0.87

3.76

1.1

3.25

4.14

u/ml

0.94

463

3302

Viral pneumonia

122

848

1.45

3.75

1.1

5.83

3.33

u/ml

0.95

438

Lateral epicondylitis

137

973

1.42

3.74

1.1

2.34

3.28

u/ml

0.35

466

Erosion of teeth , including avohilmo

377

3078

1.23

3.73

1.1

3.47

4.49

u/ml

0.67

196

1604

Other acute skin changes due to ultraviolet radiation

141

2.15

3.72

1.1

1.0

3.04

3.00

u/ml

0.01

Symptoms and signs involving the nervous and musculoskeletal systems

559

4730

1.18

3.72

1.1

4.43

4.12

u/ml

0.17

311

2403

Benign neoplasm: Liver/bile ducts

182

2.01

3.72

1.0

1.1

1.10

2.77

u/ml

1.43

Other/unspecified dorsalgia

363

2913

1.23

3.71

1.1

3.66

3.82

u/ml

0.08

202

1419

Alzheimer disease

314

0.41

3.71

1.0

1.1

0.07

1.50

u/ml

—

163

Umbilical hernia

240

1859

1.30

3.70

1.1

5.26

3.50

u/ml

0.65

134

904

Faecal incontinence

341

1.71

3.69

1.1

1.0

1.04

2.28

u/ml

1.15

152

Covid-19 confirmed case

324

2600

1.25

3.68

1.1

3.55

4.26

u/ml

0.35

179

1315

Flat foot [pes planus] (acquired)

591

1.53

3.67

1.1

4.46

3.45

u/ml

0.22

274

Other abnormal products of conception

562

3116

1.19

3.66

1.1

4.69

4.18

u/ml

0.25

270

1464

Other disorders of penis

631

1.51

3.66

1.1

5.26

4.22

u/ml

0.18

379

Explicit Sepsis, including avohilmo

230

2686

0.77

3.66

1.1

6.06

4.13

u/ml

0.70

131

1364

Chronic conjunctivitis

190

1.98

3.66

1.1

5.69

4.51

u/ml

0.15

101

Melanocytic naevi of eyelid, including canthus

3.60

3.65

1.2

1.0

2.45

2.17

u/ml

—

Defects in the complement system

2.77

3.64

1.2

1.1

1.25

6.19

u/ml

—

Obesity

767

6272

1.15

3.64

1.1

4.73

3.99

u/ml

0.41

406

3062

ILD-related respiratory insufficiency

2.88

3.63

1.2

1.1

2.60

1.47

u/ml

—

Benign neoplasm: Liver

170

2.04

3.63

1.0

1.1

1.15

3.00

u/ml

1.49

Other symptoms and signs involving the digestive system and abdomen

150

1088

1.39

3.63

1.1

2.08

3.86

u/ml

1.53

526

Other immunodeficiencies

2.47

3.62

1.1

1.44

5.17

u/ml

1.05

Heart failure and antihypertensive medication

901

0.67

3.62

1.1

5.10

2.64

u/ml

0.73

442

Other obstetric conditions, not elsewhere classified

654

3534

1.17

3.62

1.1

4.54

4.57

u/ml

0.01

346

1716

Redundant prepuce, phimosis and paraphimosis

206

1544

1.32

3.61

1.0

1.1

4.52

4.21

u/ml

0.10

121

874

Dementia

621

0.59

3.60

1.0

1.1

2.32

2.28

u/ml

0.01

316

Uterine polyps

253

1146

1.29

3.60

1.1

1.72

3.75

u/ml

2.64

132

552

Type 1 diabetes, strict (exclude DM2)

1344

0.67

3.59

1.1

2.17

4.98

u/ml

3.56

739

Rotator cuff syndrome

506

2920

1.20

3.59

1.1

2.26

3.35

u/ml

1.37

249

1371

Nephropathy related operations

671

0.53

3.59

1.0

1.1

1.18

3.67

u/ml

2.86

361

Mental retardation, wide definition

557

0.49

3.59

1.3

1.1

2.27

6.62

u/ml

1.94

355

Candidiasis

152

1108

1.38

3.58

1.1

4.48

3.51

u/ml

0.24

554

Malignant neoplasm of skin, including Hilmo

228

1970

0.77

3.57

1.1

1.32

2.88

u/ml

2.84

112

947

Dental operations

527

2272

1.20

3.57

1.1

3.20

4.02

u/ml

0.57

264

1107

Cholinergic urticaria

4.42

3.56

1.1

1.0

13.59

1.28

u/ml

—

Obesity and other hyperalimentation

767

6276

1.15

3.55

1.1

4.73

3.98

u/ml

0.41

406

3065

Unspecified/other endometriosis

150

1072

1.38

3.54

1.1

2.82

4.62

u/ml

0.83

539

Bacterial infection, other or unspecified

260

2773

0.79

3.53

1.1

5.22

3.47

u/ml

0.71

127

1406

Injury of muscle and tendon at shoulder and upper arm level

240

1872

1.29

3.52

1.1

2.30

3.00

u/ml

0.54

115

906

Implicit Sepsis

508

4428

0.84

3.52

1.1

4.72

3.93

u/ml

0.47

282

2233

Other and unspecified nerve root and plexus disorders, also in other diseases

200

1524

1.32

3.52

1.0

1.1

3.06

3.12

u/ml

0.03

100

730

Endometriosis of ovary

178

1255

1.34

3.51

1.1

2.43

4.29

u/ml

1.58

621

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

395

0.40

3.50

1.2

1.1

9.53

3.93

u/ml

—

209

Tramadol

812

4252

1.15

3.50

1.1

2.62

3.76

u/ml

1.79

425

2066

Postmenopausal bleeding

147

550

1.40

3.49

1.1

2.38

3.63

u/ml

0.69

248

Disorders of vestibular function (Vertigo)

343

2718

1.23

3.48

1.1

3.66

3.10

u/ml

0.23

171

1290

Disorders of thyroid, IBD co-morbidities

229

1210

1.30

3.48

1.1

2.89

3.35

u/ml

0.22

105

610

Falls/tendency to fall

1375

6190

1.11

3.47

1.1

4.92

3.99

u/ml

0.74

727

3109

Lyme disease, including avohilmo

298

2391

1.25

3.47

1.1

3.47

3.81

u/ml

0.13

136

1170

Lyme disease

298

2391

1.25

3.47

1.1

3.47

3.81

u/ml

0.13

136

1170

malignant neoplasm of male genital organs

625

0.62

3.47

1.0

1.1

1.62

2.45

u/ml

0.56

327

Olecranon bursitis

251

1.81

3.45

1.1

6.52

2.63

u/ml

0.59

128

Budesonide

144

1048

1.38

3.44

1.1

2.22

2.67

u/ml

0.24

477

Hernia of abdominal wall

361

2959

1.22

3.44

1.1

4.65

3.64

u/ml

0.46

198

1435

Implicit Sepsis, including avohilmo

624

5178

0.86

3.43

1.1

4.39

3.93

u/ml

0.27

337

2610

Coronary artery bypass grafting

405

0.49

3.42

1.0

2.87

2.61

u/ml

0.06

199

Other viral hepatitis, including avohilmo

671

0.55

3.42

1.1

2.91

3.73

u/ml

0.20

337

Bacterial Sepsis

193

2083

0.76

3.40

1.0

1.1

4.78

3.78

u/ml

0.33

103

1052

Lumbar disc prolapse

640

4076

1.16

3.40

1.1

3.60

3.52

u/ml

0.04

332

1971

Gluteal tendinitis

238

1.83

3.40

1.1

2.00

1.92

u/ml

0.04

105

Other disorders starting during childhood or adolecense, excluding more controls

123

836

1.43

3.39

1.1

2.15

5.64

u/ml

4.85

498

Haemorrhoids and perianal venous thrombosis

252

1974

1.27

3.38

1.0

1.1

3.14

3.54

u/ml

0.13

113

981

Injuries to the neck

288

2311

1.25

3.38

1.1

3.33

4.47

u/ml

0.82

157

1174

Malignant neoplasm of respiratory system and intrathoracic organs

471

0.51

3.36

1.0

1.1

0.59

2.56

u/ml

2.48

239

Mental retardation

543

0.50

3.36

1.3

1.1

2.27

6.69

u/ml

1.98

349

Diagnoses used for exclusion with ILD

167

1249

1.34

3.35

1.1

2.95

3.34

u/ml

0.13

610

Type 1 diabetes, definitions combined

1347

0.68

3.35

1.1

3.28

4.91

u/ml

0.77

739

Toxic effect of contact with venomous animals

307

1.72

3.33

1.1

3.88

4.23

u/ml

0.06

161

Chronic periodontitis, complicated

295

3550

0.81

3.31

1.0

1.1

6.03

3.28

u/ml

0.87

156

1687

Malignant neoplasm of skin

204

1786

0.77

3.30

1.1

1.37

2.83

u/ml

2.22

100

865

Benign lipomatous neoplasm

223

1740

1.29

3.30

1.0

1.1

4.39

3.37

u/ml

0.14

113

853

Other/unspecified disorders of vestibular function

169

1.97

3.30

1.1

1.0

0.61

3.22

u/ml

2.36

Acute lymphadenitis

567

1.52

3.29

1.1

3.24

3.68

u/ml

0.17

294

Other functional intestinal disorders

434

3300

1.20

3.29

1.1

2.85

4.68

u/ml

2.31

223

1725

Idiopathic pulmonary fibrosis

128

2.12

3.29

1.1

1.0

4.03

1.16

u/ml

0.51

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

534

4465

1.17

3.28

1.1

5.12

3.61

u/ml

0.49

280

2164

Spirochaetal infections, other/unspecified, including avohilmo

299

2418

1.24

3.27

1.1

3.47

4.02

u/ml

0.23

136

1188

Erysipelas

281

3005

0.80

3.27

1.1

5.80

3.00

u/ml

1.91

170

1456

Viral hepatitis, including avohilmo

724

0.57

3.25

1.1

2.79

3.89

u/ml

0.29

365

Shoulder lesions

697

3621

1.16

3.24

1.1

2.77

3.62

u/ml

0.87

341

1742

Nonorganic sleeping disorders

295

2391

1.24

3.19

1.1

3.57

4.39

u/ml

0.34

149

1208

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

229

1.82

3.19

1.0

1.1

2.22

5.17

u/ml

0.86

106

Inhalation and ingestion of food causing obstruction of respiratory tract

2.80

3.19

1.4

1.1

6.55

4.72

u/ml

—

Alzheimer disease, including avohilmo

369

0.51

3.19

1.0

1.1

0.08

1.63

u/ml

3.24

188

Bacterial infection, other or unspecified, including avohilmo

326

3254

0.82

3.18

1.1

4.96

3.71

u/ml

0.59

166

1645

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

120

860

1.40

3.18

1.0

1.1

1.41

2.96

u/ml

2.51

412

Atherosclerosis, excluding cerebral and coronary sclerosis

803

0.64

3.18

1.1

2.15

2.16

u/ml

0.00

397

Other diseases of stomach and duodenum

229

1.80

3.16

1.2

1.0

3.78

1.79

u/ml

0.62

107

Haemorrhage in early pregnancy

377

3046

1.21

3.14

1.1

4.37

4.34

u/ml

0.01

167

1446

Congenital malformations, deformations and chromosomal abnormalities

812

6790

1.14

3.14

1.1

5.77

4.18

u/ml

0.93

439

3469

Viral infections characterized by skin and mucous membrane lesions

443

3737

1.19

3.12

1.1

6.45

4.15

u/ml

1.48

233

1938

Immunodeficiencies

352

1.64

3.10

1.1

4.66

4.65

u/ml

0.00

185

Complications of medical and surgical care

699

5487

1.15

3.10

1.1

5.50

3.58

u/ml

0.88

363

2650

Other complications of surgical and medical care, not elsewhere classified

681

1.45

3.10

1.2

1.1

3.10

3.21

u/ml

0.05

333

Nausea and vomiting

256

1997

1.25

3.10

1.1

2.23

5.18

u/ml

3.53

148

1064

Lichen ruber planus, wide definition including periferal and oral lichen planus

163

1232

1.33

3.08

1.1

2.06

3.09

u/ml

0.46

576

Other enthesopathy of foot (+metatarsalgia)

106

748

1.43

3.08

1.1

2.40

3.21

u/ml

0.35

357

Post-traumatic stress disorder

159

1201

1.34

3.07

1.2

1.1

5.75

4.79

u/ml

0.15

616

Malignant neoplasm of bronchus and lung

359

0.46

3.07

1.0

1.1

0.90

2.48

u/ml

—

179

Other epidermal thickening

254

1.75

3.06

1.1

1.0

4.02

3.59

u/ml

0.08

131

Type 1 diabetes, strict definition, subgroup 1

1169

0.68

3.06

1.1

2.36

5.09

u/ml

2.97

654

Heart failure and bmi 25plus

837

0.68

3.06

1.1

3.18

2.77

u/ml

0.12

403

Benign neoplasm: Duodenum

2.61

3.05

1.3

1.1

2.18

1.49

u/ml

0.24

Other congenital malformations of skin, including avohilmo

108

767

1.42

3.05

1.1

10.46

4.76

u/ml

0.59

397

Continuous positive airway pressure

170

1075

1.32

3.05

1.1

4.31

4.75

u/ml

0.12

565

Other and unspecified disorders of vitreous body

249

1945

1.25

3.04

1.1

2.55

2.96

u/ml

0.22

111

897

Fall on same level involving ice and snow

576

4976

1.16

3.03

1.1

4.74

3.88

u/ml

0.42

299

2508

Disorders of lipoprotein metabolism and other lipidaemias

540

3820

0.86

3.03

1.1

3.35

3.42

u/ml

0.04

303

1782

Other disorders of male genital organs

255

1.74

3.03

1.0

1.1

1.62

2.74

u/ml

0.68

149

MS-disease / Multiple Sclerosis

720

0.59

3.00

1.0

1.1

1.65

3.19

u/ml

0.95

363

Pedestrian injured in collision with pedal cycle

197

1.85

3.00

1.0

1.1

3.42

2.52

u/ml

0.12

106

Status post-ami

454

0.55

3.00

1.0

1.1

8.56

2.62

u/ml

0.66

222

Retinal breaks without detachment

107

760

1.41

3.00

1.1

1.35

3.00

u/ml

2.68

355

Other viral hepatitis

631

0.56

3.00

1.1

2.91

3.42

u/ml

0.12

312

Diseases of inner ear

401

3221

1.19

2.99

1.1

3.32

3.47

u/ml

0.06

201

1534

COPD, hospital admissions 3, with asthma pneumonia sepsis

563

1.45

2.99

1.1

5.53

1.96

u/ml

1.23

284

Pre-eclampsia or poor fetal growth

322

3872

0.82

2.98

1.1

3.11

4.34

u/ml

1.10

157

1851

Kidney transplant status

394

0.45

2.98

1.0

1.1

2.59

4.61

u/ml

0.77

221

Infections of the skin and subcutaneous tissue

682

5878

1.14

2.97

1.1

4.85

4.13

u/ml

0.53

386

3050

Type 1 diabetes, strict definition

1220

0.69

2.97

1.1

3.43

5.02

u/ml

0.69

678

Exclusions for E4_PCOS_CONSORTIUM

782

5522

0.88

2.96

1.1

3.96

4.44

u/ml

0.31

346

2788

Abrasion of teeth

347

2883

1.21

2.95

1.1

2.75

3.84

u/ml

1.01

182

1348

Implicit viral Sepsis, including avohilmo

243

1941

1.25

2.95

1.1

6.91

4.09

u/ml

1.19

149

976

Oral lichen planus

101

2.20

2.94

1.1

1.0

1.55

2.74

u/ml

0.63

Acute nasopharyngitis (common cold)

128

934

1.37

2.93

1.1

4.69

3.70

u/ml

0.34

472

Other specified/unspecified soft tissue disorders

206

1.81

2.91

1.1

1.0

3.63

3.47

u/ml

0.03

Hypertensive diseases

724

4642

0.88

2.91

1.1

3.42

3.85

u/ml

0.31

368

2229

Viral hepatitis

676

0.59

2.91

1.1

2.91

3.73

u/ml

0.20

335

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.54

2.89

1.3

1.0

2.29

1.85

u/ml

—

Herpesviral [herpes simplex] infections

123

902

1.37

2.88

1.1

9.19

3.33

u/ml

2.25

448

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

651

0.58

2.88

1.1

2.78

3.44

u/ml

0.10

318

Vulvovaginal ulceration/inflammation in other diseases

109

785

1.40

2.88

1.2

1.1

4.80

3.96

u/ml

0.18

387

Carpal tunnel syndrome

554

4151

1.16

2.86

1.1

2.35

3.60

u/ml

2.04

264

1937

Impacted teeth

418

3041

1.19

2.84

1.1

4.25

5.30

u/ml

0.75

242

1677

Hypertension

724

4633

0.88

2.84

1.1

3.42

3.85

u/ml

0.31

368

2224

Melanoma in situ

123

2.05

2.82

1.0

0.71

3.27

u/ml

2.06

Nonalcoholic fatty liver disease

104

745

1.41

2.82

1.1

1.16

3.23

u/ml

2.88

354

Liquid cancers

104

1360

0.72

2.81

1.1

3.24

3.66

u/ml

0.09

692

Cervicobrachial syndrome

206

1629

1.27

2.81

1.1

2.04

3.19

u/ml

0.81

106

747

Suicide or other Intentional self-harm

200

2522

0.79

2.80

1.1

4.68

4.15

u/ml

0.19

109

1279

Mycoses

261

2122

1.23

2.79

1.1

4.51

3.75

u/ml

0.29

129

1058

Cervical polyps

539

1.47

2.78

1.1

2.54

3.78

u/ml

0.32

240

Melanocytic naevi

345

2885

1.20

2.77

1.1

3.13

4.24

u/ml

0.90

179

1440

Heart failure and coronary heart disease

893

0.70

2.76

1.1

4.18

2.36

u/ml

0.60

447

Disorders of breast

570

4363

1.15

2.76

1.1

3.42

4.23

u/ml

0.36

267

2062

Combinations of oral blood glucose lowering drugs

1256

0.71

2.75

1.1

1.0

3.36

3.02

u/ml

0.06

607

Use of anticholinesterases

389

0.53

2.74

1.0

1.1

0.20

1.52

u/ml

—

202

N06DA Anticholinesterases

389

0.53

2.74

1.0

1.1

0.20

1.52

u/ml

—

202

Other shoulder lesions

102

732

1.40

2.74

1.1

6.12

3.23

u/ml

0.63

358

Other disorders of cornea

549

1.47

2.74

1.1

11.87

2.61

u/ml

0.68

253

Pleural plaque

2.20

2.73

1.1

3.87

1.00

u/ml

—

Major coronary heart disease event excluding revascularizations

213

1762

0.80

2.73

1.1

4.47

2.81

u/ml

0.80

111

869

Endometriosis of rectovaginal septum and vagina

493

1.49

2.71

1.1

0.96

3.98

u/ml

3.15

228

Other abnormal uterine and vaginal bleeding

205

1163

1.27

2.71

1.1

6.02

4.29

u/ml

0.49

108

585

Other and unspecified acute skin changes due to ultraviolet radiation

2.62

2.71

1.1

5.70

1.81

u/ml

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

3.47

2.69

1.0

1.1

9.05

1.75

u/ml

—

Inflammatory disease of uterus

191

1508

1.27

2.68

1.1

3.32

4.86

u/ml

0.63

732

malignant neoplasm of male genital organs, including Hilmo

657

0.68

2.68

1.0

1.1

1.55

2.45

u/ml

0.70

346

Hypertrophy of tongue papillae

2.37

2.67

1.1

1.0

0.54

1.66

u/ml

1.28

malignant neoplasm of female genital organs, including Hilmo

806

0.65

2.67

1.0

1.1

5.81

3.34

u/ml

0.33

379

Atypical facial pain

327

1.60

2.67

1.2

1.1

2.07

3.89

u/ml

0.99

161

Zoster [herpes zoster], including avohilmo

399

3270

1.18

2.66

1.1

5.39

3.52

u/ml

1.12

200

1595

Other disorders of breast

152

1166

1.31

2.66

1.1

1.28

4.14

u/ml

5.60

560

Myotonic disorders

2.73

2.66

1.2

1.0

2.42

1.20

u/ml

—

Endometriosis ASRM stages 1,2

231

1867

1.24

2.65

1.1

1.22

4.51

u/ml

6.69

111

907

Colonic or urogenital fistula

233

1884

1.24

2.64

1.1

3.49

3.40

u/ml

0.03

100

933

Infections with a predominantly sexual mode of transmission

455

3906

1.17

2.63

1.1

4.40

4.29

u/ml

0.04

222

1982

Mental and behavioural disorders due to opioids

427

0.51

2.63

1.0

1.1

5.83

3.54

u/ml

0.21

226

Benign neoplasm of other and ill-defined parts of digestive system

110

805

1.37

2.63

1.1

2.59

2.94

u/ml

0.12

379

Generalized skin eruption due to drugs and medicaments

259

1.68

2.62

1.0

1.1

4.38

4.41

u/ml

0.01

129

Mental and behavioural disorders due to use of other stimulants, including caffeine

359

0.47

2.62

1.1

1.49

3.26

u/ml

—

190

Hypothyroidism (congenital or acquired)

449

2148

1.17

2.62

1.1

3.27

4.60

u/ml

1.14

223

1108

Pneumonia due to other infectious organisms, not elsewhere classified

141

1.93

2.61

1.1

1.0

0.95

2.20

u/ml

1.17

Contraceptive management

548

3332

1.15

2.60

1.1

3.98

4.17

u/ml

0.06

263

1637

Patellar tendinitis

156

1.89

2.60

1.1

4.64

4.88

u/ml

0.03

Stenosis and insufficiency of lacrimal passages

482

1.48

2.58

1.1

7.60

3.29

u/ml

0.76

235

Unspecified fall

493

4191

1.16

2.58

1.1

5.47

4.41

u/ml

0.62

277

2188

Hypothyroidism, strict autoimmune, 3 medication purchases required

908

5475

1.12

2.58

1.1

2.82

4.26

u/ml

2.45

425

2711

Antihypertensive medication - note that there are other indications

1054

4975

1.11

2.58

1.1

4.99

4.47

u/ml

0.34

547

2604

Disorders of orbit

268

1.66

2.57

1.1

1.91

2.00

u/ml

0.03

126

Single spontaneous delivery

333

2098

0.84

2.57

1.1

4.75

4.60

u/ml

0.05

181

1071

Later onset COPD

269

1.58

2.56

1.0

4.91

1.47

u/ml

0.64

142

Bruxism

179

1.82

2.55

1.1

1.36

2.52

u/ml

1.03

Deficiency of other B group vitamins

2.25

2.55

1.1

1.0

0.35

2.92

u/ml

—

Chronic viral hepatitis

538

0.57

2.55

1.1

3.14

3.35

u/ml

0.04

270

Chronic suppurative otitis media, including avohilmo

625

1.42

2.54

1.1

5.85

3.82

u/ml

0.44

344

Thyroiditis, ILD-related definition

135

1027

1.32

2.53

1.1

2.43

3.56

u/ml

0.54

501

Fall on and from stairs and steps

237

1930

1.23

2.53

1.1

3.11

4.18

u/ml

0.68

140

971

Disorders of iron metabolism

2.19

2.53

1.1

1.0

1.41

2.26

u/ml

—

Other viral diseases, not elsewhere classified

247

2015

1.23

2.53

1.1

5.11

4.69

u/ml

0.13

131

1084

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

2.53

0.0

1.1

—

7.20

—

Benign paroxysmal vertigo

197

1572

1.26

2.52

1.1

4.15

3.00

u/ml

0.32

742

Mental retardation, excluding more controls

467

0.55

2.51

1.3

1.1

2.42

6.01

u/ml

1.35

287

Polyarteritis nodosa and related conditions

2.36

2.50

1.2

1.0

0.73

2.40

u/ml

1.04

Other and unspecified mental retardation

293

0.43

2.50

1.1

3.53

6.14

u/ml

—

209

Keratoconus

180

1.80

2.50

1.1

23.54

1.84

u/ml

0.69

Benign neoplasm of middle ear and respiratory system

325

1.58

2.49

1.1

3.63

3.07

u/ml

0.15

163

Anogenital herpesviral [herpes simplex] infection, including avohilmo

187

1489

1.26

2.49

1.1

4.25

4.39

u/ml

0.03

775

Benign neoplasm: Colon

286

2228

1.21

2.48

1.1

2.03

2.97

u/ml

0.90

131

1066

Mental and behavioural disorders due to cannabinoids

391

0.50

2.48

1.1

10.31

3.80

u/ml

0.61

210

Other maternal disorders predominantly related to pregnancy

755

4207

1.13

2.47

1.1

3.79

4.43

u/ml

0.44

354

2031

Complications predominantly related to the puerperium

348

2949

1.19

2.47

1.1

3.37

4.22

u/ml

0.43

173

1428

Peripheral artery operations in Hilmo

312

0.45

2.46

1.2

1.1

0.29

1.91

u/ml

—

164

Tracheo-bronchomalasia

3.00

2.46

1.1

1.0

3.87

2.95

u/ml

—

Other retinal disorders

311

2813

0.84

2.46

1.1

2.73

3.47

u/ml

0.61

156

1409

Haemangioma and lymphangioma, any site

663

1.40

2.46

1.1

10.80

4.53

u/ml

0.42

339

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

147

1887

0.77

2.45

1.1

4.93

4.41

u/ml

0.14

957

Other noninflammatory disorders of vagina

563

1.43

2.44

1.1

1.48

4.32

u/ml

2.20

262

Concussion

633

4335

1.13

2.44

1.1

5.67

4.32

u/ml

0.72

349

2259

Complications of procedures, not elsewhere classified

820

5924

1.12

2.44

1.1

4.62

3.75

u/ml

0.37

416

2884

Other sleep disorders

106

783

1.36

2.43

1.1

2.90

3.97

u/ml

0.32

389

Metatarsalgia

682

1.39

2.41

1.1

2.23

3.34

u/ml

0.49

326

Oter anti-inflammatory and antirheumatic agents, non-steroids

382

1.40

2.41

1.1

1.81

3.08

u/ml

0.89

191

Hypothyroidism and >3 levothyroxin purchases

443

2136

1.17

2.41

1.1

3.52

4.62

u/ml

0.81

220

1099

Hypothyroidism, levothyroxine purchases

443

2136

1.17

2.41

1.1

3.52

4.62

u/ml

0.81

220

1099

Examination and encounter for administrative purposes

312

1.58

2.41

1.1

1.0

1.41

3.19

u/ml

1.21

120

Habitual aborter

251

1.66

2.40

1.1

2.51

3.76

u/ml

0.43

120

Short Achilles tendon (acquired)

153

1.85

2.40

1.0

3.24

3.38

u/ml

0.02

Injury of muscle and tendon at lower leg level

131

1001

1.31

2.39

1.1

2.78

3.06

u/ml

0.12

494

Hernia of abdominal wall, postoperative

143

1098

1.30

2.38

1.1

4.68

3.75

u/ml

0.21

534

Persistent delusional disorders

439

0.54

2.38

1.1

4.42

2.61

u/ml

0.35

216

Contracture of joint

2.54

2.37

1.0

7.70

3.01

u/ml

—

Actinic keratosis

109

736

1.35

2.37

1.1

2.28

1.96

u/ml

0.11

365

Presence of other devices

127

951

1.32

2.37

1.1

2.31

3.32

u/ml

0.47

466

Crushed, pushed or stepped on by crowd or human stampede

119

900

1.33

2.37

1.1

4.67

4.71

u/ml

0.01

477

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

354

1.54

2.36

1.0

1.1

3.11

3.39

u/ml

0.06

176

Localized swelling, mass and lump of skin and subcutaneous tissue

288

2410

1.20

2.36

1.1

3.50

3.98

u/ml

0.23

149

1210

Other congenital malformations of skin

387

1.52

2.35

1.1

15.33

6.25

u/ml

0.56

213

Sequelae of cerebrovascular disease

1063

0.73

2.35

1.0

1.1

5.98

2.45

u/ml

0.69

521

Other reaction to severe stress, and adjustment disorders

507

4435

1.15

2.35

1.1

5.32

4.22

u/ml

0.62

277

2187

Disorders of refraction and accommodation

381

3255

1.17

2.34

1.1

6.40

4.61

u/ml

0.42

197

1720

Other and unspecified visual disturbances

652

1.39

2.34

1.2

1.1

1.46

3.08

u/ml

1.29

315

Demyelinating diseases of the central nervous system

817

0.67

2.33

1.0

1.1

1.34

3.40

u/ml

2.06

406

All influenza (not pneumonia)

155

1216

1.28

2.33

1.1

5.60

4.48

u/ml

0.31

632

Unspecified event, undetermined intent

207

1.71

2.33

1.1

6.33

3.96

u/ml

0.34

109

Malignant neoplasm of bronchus and lung, including Hilmo

439

0.59

2.32

1.1

6.48

2.39

u/ml

0.49

212

malignant neoplasm of female genital organs

693

0.65

2.31

1.0

1.1

6.24

3.35

u/ml

0.34

323

Other/unspecified synovitis and tenosynovitis

105

782

1.35

2.30

1.0

1.1

2.67

2.81

u/ml

0.05

374

Oral lichen planus, including avohilmo , including avohilmo

356

1.53

2.30

1.1

1.54

2.58

u/ml

0.71

167

Other and unspecified polyneuropathies, also in other diseases

723

1.36

2.27

1.1

5.22

2.52

u/ml

0.73

348

Superficial injury of hip and thigh

110

826

1.34

2.27

1.1

8.49

3.31

u/ml

0.72

412

Ulcer of vagina/vulva

247

1.64

2.27

1.1

1.0

3.35

5.39

u/ml

0.61

126

Procreative management

479

3444

1.15

2.27

1.1

5.38

4.75

u/ml

0.19

273

1823

Seropositive rheumatoid arthritis, strict definition

837

0.68

2.27

1.1

1.25

3.22

u/ml

2.18

392

Intestinal adhesions without obstruction

317

1.55

2.27

1.0

1.1

5.99

2.63

u/ml

0.41

171

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

145

1132

1.29

2.26

1.1

5.15

4.30

u/ml

0.21

594

Fracture of femur

766

0.68

2.26

1.0

1.1

6.11

3.21

u/ml

0.36

399

Rheumatism, unspecified

725

1.36

2.25

1.1

1.0

3.35

2.64

u/ml

0.18

334

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

338

2885

1.18

2.24

1.1

4.93

4.27

u/ml

0.24

172

1489

Subacute thyroiditis

248

1.63

2.23

1.1

1.0

4.37

2.49

u/ml

0.21

120

Sciatica+with lumbago

494

3832

1.14

2.23

1.1

4.97

3.45

u/ml

1.11

257

1831

Melanoma in situ of trunk

2.89

2.21

1.0

1.1

0.18

1.46

u/ml

—

Haemangioma, any site

600

1.39

2.21

1.1

4.25

4.83

u/ml

0.11

309

Poisoning by medicine

195

2390

0.81

2.20

1.1

5.53

4.42

u/ml

0.39

107

1220

Hard cardiovascular diseases

603

4012

0.89

2.20

1.1

4.09

3.71

u/ml

0.23

287

1966

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

180

1.74

2.19

1.1

4.32

2.96

u/ml

0.27

L04AA Selective immunosuppressants

148

1868

0.79

2.18

1.0

1.1

4.64

4.29

u/ml

0.10

933

Peroneal tendinitis

122

1.91

2.18

1.0

1.1

0.69

2.51

u/ml

1.59

Pure hypercholesterolaemia

450

3274

0.87

2.18

1.1

3.28

3.45

u/ml

0.11

264

1518

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

566

0.65

2.17

1.1

4.55

2.89

u/ml

0.25

287

Dislocation, sprain and strain of joint and ligaments of hip

151

1.80

2.16

1.1

1.0

7.49

1.90

u/ml

0.64

Skin changes due to chronic exposure to nonionizing radiation

117

807

1.31

2.16

1.1

2.16

2.17

u/ml

0.00

398

Hypertensive heart and/or renal disease

599

0.68

2.16

1.1

1.05

2.67

u/ml

1.75

290

Pneumonia due to Streptococcus pneumoniae

227

1.64

2.15

1.1

1.0

16.12

2.66

u/ml

0.66

112

Bacterial pneumonia, not elsewhere classified

291

2157

1.19

2.15

1.1

3.74

4.05

u/ml

0.14

181

1067

Otitis media, unspecified

198

1489

1.23

2.13

1.2

1.1

5.83

5.06

u/ml

0.26

135

841

Other sexually transmitted chlamydial diseases, including avohilmo

207

1702

1.23

2.12

1.1

3.66

4.93

u/ml

0.57

113

931

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

292

0.48

2.12

1.1

0.38

3.54

u/ml

—

131

Secondary uncertain malignant neoplasm

486

0.59

2.11

1.1

3.78

3.52

u/ml

0.03

240

Injury of muscle and tendon at hip and thigh level

734

1.34

2.10

1.1

3.47

3.02

u/ml

0.14

351

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

175

1.73

2.10

1.2

1.0

0.40

2.30

u/ml

3.35

ILD medications: immunosuppressive drugs

627

5073

1.12

2.09

1.1

5.53

3.74

u/ml

1.29

316

2407

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

439

3798

1.15

2.09

1.1

4.92

4.60

u/ml

0.11

252

1974

Coxarthrosis [arthrosis of hip](FG)

255

2092

0.84

2.09

1.1

1.59

3.27

u/ml

2.66

114

969

Hallux rigidus

539

1.40

2.07

1.1

5.87

2.63

u/ml

0.75

247

Acne

214

1760

1.22

2.07

1.1

6.60

4.54

u/ml

0.35

128

981

Other/unspecified soft tissue disorders related to use, overuse and pressure

199

1.68

2.07

1.1

1.0

2.35

4.06

u/ml

0.42

Implicit fungal Sepsis, including avohilmo

333

1.51

2.06

1.2

1.1

5.83

3.85

u/ml

0.24

162

Abnormal findings on diagnostic imaging of breast

2.21

2.06

1.1

1.0

1.98

1.99

u/ml

—

Bacterial pneumoniae

314

2352

1.17

2.06

1.1

4.84

3.91

u/ml

0.29

196

1180

Polyuria

138

1086

1.27

2.06

1.1

1.09

2.94

u/ml

3.16

546

Impingement syndrome of shoulder

155

1238

1.26

2.04

1.1

2.55

2.93

u/ml

0.21

589

Exophthalmic conditions

2.44

2.04

1.0

4.55

1.41

u/ml

—

Mental and behavioural disorders due to sedatives or hypnotics

590

0.64

2.04

1.1

7.61

3.30

u/ml

0.61

292

Congenital malformations of the respiratory system

170

1.74

2.03

1.2

1.1

3.89

7.22

u/ml

0.58

106

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

327

1.52

2.03

1.1

3.22

4.50

u/ml

0.33

173

Other skin changes

136

1071

1.27

2.02

1.1

5.34

3.77

u/ml

0.42

530

Care involving use of rehabilitation procedures

622

5006

1.12

2.02

1.1

4.01

3.97

u/ml

0.02

362

2446

Implicit bacterial Sepsis

154

1645

0.80

2.02

1.1

4.07

3.34

u/ml

0.23

819

Lichen planus, including avohilmo

129

1011

1.28

2.00

1.1

2.22

3.17

u/ml

0.31

477

Sequelae of injuries, of poisoning and of other consequences of external causes

221

1838

1.21

2.00

1.1

4.51

3.61

u/ml

0.32

112

908

Glaucoma suspect

192

1573

1.22

2.00

1.1

2.02

2.89

u/ml

0.54

760

Use of biperiden

285

0.49

1.99

1.0

1.1

5.42

2.00

u/ml

—

143

Other demyelinating diseases of the central nervous system

375

0.55

1.99

1.0

1.1

2.38

2.93

u/ml

0.16

182

Noninfectious colitis NAS

135

1066

1.27

1.98

1.1

2.28

3.90

u/ml

1.17

546

Postpartum care and examination

199

1513

0.82

1.98

1.1

5.48

5.19

u/ml

0.07

100

727

Care involving dialysis

401

0.57

1.98

1.0

1.1

1.83

3.93

u/ml

1.17

215

Respiratory tuberculosis, not confirmed

2.29

1.98

1.0

7.61

2.56

u/ml

—

Poisoning by drugs, medicaments and biological substances

220

2632

0.83

1.97

1.1

5.17

4.24

u/ml

0.36

121

1340

Acute epiglottitis

2.05

1.97

1.2

1.0

0.68

2.87

u/ml

1.22

Maternal care for other known or suspected fetal problems

353

2556

0.86

1.97

1.1

5.10

4.94

u/ml

0.05

168

1260

Reimbursement for rheumatic diseases

413

4678

0.88

1.97

1.0

1.1

3.05

4.16

u/ml

0.84

205

2325

Myocardial infarction, strict

138

1230

0.79

1.96

1.1

4.64

2.80

u/ml

0.69

601

Non-ischemic cardiomyopathy

866

0.74

1.96

1.1

3.13

2.38

u/ml

0.20

435

Pain associated with micturition

103

787

1.31

1.95

1.0

1.1

7.46

4.28

u/ml

0.87

404

Severe mental retardation

0.00

1.95

0.0

1.1

—

5.30

—

Other gastritis (incl. Duodenitis)

130

1024

1.27

1.94

1.1

3.01

3.59

u/ml

0.22

487

Autonomic disorders

157

1.74

1.94

1.0

1.1

1.03

3.38

u/ml

1.70

Neuromuscular dysfunction of bladder

437

1.43

1.94

1.1

3.43

2.34

u/ml

0.28

223

Exposure to other and unspecified inanimate mechanical forces

693

1.34

1.94

1.1

3.69

3.74

u/ml

0.01

364

Periapical abscess

353

4062

0.87

1.94

1.1

5.09

4.06

u/ml

0.51

198

2003

Meniscus derangement

460

2685

1.14

1.93

1.1

2.67

3.35

u/ml

0.58

229

1240

Acute generalized exanthematous pustulosis

298

1.52

1.93

1.0

1.1

4.26

4.66

u/ml

0.10

150

Parkinson's disease, including avohilmo

335

0.54

1.93

1.1

1.44

2.53

u/ml

—

168

Cardiomyopathy (excluding other)

498

0.62

1.93

1.2

1.1

3.56

2.72

u/ml

0.13

252

Myocardial infarction

156

1351

0.81

1.93

1.1

5.00

2.67

u/ml

1.05

652

Other local infections of skin and subcutaneous tissue

719

1.33

1.93

1.1

7.67

3.81

u/ml

1.00

367

Aplastic and other anaemias

179

1995

0.82

1.92

1.1

2.27

3.50

u/ml

1.22

1009

Intentional self-harm by jumping from a high place

0.00

1.91

0.0

1.0

—

2.16

—

Other predominantly sexually transmitted diseases, not elsewhere classified

252

2133

1.19

1.91

1.1

4.78

4.41

u/ml

0.10

126

1081

Other or unspecified immunodeficiency

3.29

1.90

1.3

1.0

1.00

8.08

u/ml

—

Malignant neoplasm of prostate

509

0.71

1.90

1.0

1.1

1.73

2.46

u/ml

0.41

261

False labour

524

2889

1.13

1.90

1.1

3.70

4.84

u/ml

0.77

248

1401

Parkinson's disease

320

0.53

1.90

1.1

1.59

2.58

u/ml

—

162

Leukaemia of unspecified cell type

0.00

1.90

0.0

1.0

—

1.52

—

Chronic suppurative otitis media

490

1.40

1.89

1.1

6.62

4.08

u/ml

0.46

260

Delivery

348

2117

0.86

1.89

1.1

4.36

4.59

u/ml

0.09

188

1083

Mild mental retardation

278

0.50

1.89

1.4

1.1

1.25

5.05

u/ml

—

170

Other/unspecified enthesopathies of lower limb, excluding foot

550

1.37

1.88

1.0

1.1

2.78

3.03

u/ml

0.08

267

Type1 diabetes, definitions combined, early onset

1039

0.74

1.88

1.1

2.88

5.36

u/ml

1.26

588

Medicines for HER+ breast cancer

187

2104

0.83

1.86

1.1

1.80

3.52

u/ml

2.90

947

Other disorders starting during childhood or adolescence

126

988

1.28

1.86

1.1

2.70

6.04

u/ml

3.00

603

Sacrococcygeal disorders, not elsewhere classified

221

1.60

1.86

1.2

1.1

1.56

2.92

u/ml

0.58

106

Disorders of muscles

706

1.32

1.86

1.1

1.51

3.57

u/ml

2.10

341

Thyroiditis

526

1.38

1.86

1.1

5.17

3.90

u/ml

0.20

257

Malignant neoplasm of ovary, including Hilmo

264

0.49

1.85

1.0

1.1

0.41

3.98

u/ml

—

118

Lichen planus

577

1.36

1.85

1.1

0.98

3.02

u/ml

2.66

271

Gingivitis and periodontal diseases

1053

5002

1.09

1.85

1.1

4.20

4.09

u/ml

0.05

552

2461

Spontaneous abortion

576

3453

1.12

1.85

1.1

3.15

4.10

u/ml

0.79

273

1641

Covid-19 suspected case

281

2407

1.17

1.85

1.1

3.24

4.68

u/ml

1.08

162

1215

Respiratory tuberculosis, not confirmed, including avohilmo

2.21

1.84

1.0

7.61

2.67

u/ml

—

Ventral hernia

156

1265

1.24

1.84

1.1

3.66

3.49

u/ml

0.05

602

Other and unspecified disorders of skin and subcutaneous tissue

327

1.48

1.81

1.2

1.1

1.82

3.25

u/ml

0.66

156

Transient ischemic attack

174

1682

0.82

1.80

1.1

2.25

2.64

u/ml

0.15

101

805

Other disorders of conjunctiva

537

1.36

1.80

1.1

4.06

2.13

u/ml

0.56

247

Deep bite that required surgery

109

1.87

1.80

1.1

9.77

2.57

u/ml

0.48

Immunodeficiency with predominantly antibody defects

192

1.63

1.79

1.1

8.25

4.95

u/ml

0.27

Alzheimer disease, excluding more controls

196

0.53

1.79

1.0

1.1

0.08

1.51

u/ml

—

101

Viral pneumonia (unknown virus, not influenza)

462

1.39

1.78

1.1

6.81

3.11

u/ml

0.94

238

Open wound of wrist and hand

503

4339

1.12

1.78

1.1

5.56

4.04

u/ml

0.90

259

2245

Traumatic subdural haemorrhage

340

0.58

1.77

1.1

7.78

2.11

u/ml

—

176

severe traumatic brain injury, does not include concussion

899

0.73

1.77

1.1

7.23

3.33

u/ml

0.83

457

Atrial fibrillation and flutter

195

1510

0.83

1.77

1.1

3.85

3.27

u/ml

0.20

701

Hypertensive Heart Disease

516

0.69

1.77

1.0

1.1

1.01

2.54

u/ml

1.55

252

Polymorphous light eruption

2.27

1.76

1.3

1.0

1.75

2.26

u/ml

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

285

2454

1.16

1.76

1.1

2.98

3.55

u/ml

0.39

154

1253

Inflammatory disorders of breast

705

1.31

1.76

1.1

3.15

4.06

u/ml

0.24

343

Otitis externa, unspecified

124

987

1.26

1.75

1.2

1.1

2.39

3.71

u/ml

0.93

504

Female infertility, tubal origin

405

1.42

1.75

1.1

3.45

3.94

u/ml

0.11

180

Poor fetal growth

149

1823

0.81

1.75

1.1

3.58

4.29

u/ml

0.27

893

Suppurative otitis media, unspecified

217

1.58

1.75

1.0

1.1

10.38

5.09

u/ml

0.39

121

Benign neoplasm: Skin of ear and external auricular canal

132

1.75

1.74

1.0

1.16

2.97

u/ml

0.74

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

155

1265

1.23

1.73

1.1

4.80

4.19

u/ml

0.16

663

Osteopathies and chondropathies

475

3868

1.12

1.73

1.1

4.00

4.05

u/ml

0.02

248

1939

Lymphoid leukaemia

217

0.46

1.73

1.3

1.1

1.14

3.90

u/ml

—

126

Exposure to other and unspecified forces of nature

2.35

1.73

1.0

1.1

1.24

1.67

u/ml

—

Radiculopathy

741

1.30

1.72

1.1

1.47

2.78

u/ml

1.42

345

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

307

1.48

1.72

1.1

6.03

3.29

u/ml

0.41

152

Asymmetry of jaw

164

1.68

1.71

1.1

8.29

5.32

u/ml

0.21

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.31

1.71

1.0

0.31

1.63

u/ml

—

Diabetes insipidus

0.00

1.71

0.0

1.0

—

2.68

—

Atrial septal defect

440

0.63

1.70

1.1

1.50

7.35

u/ml

5.81

280

Malignant neoplasm of bone and articular cartilage

0.00

1.69

0.0

1.0

—

1.85

—

Benign neoplasm: Skin of eyelid, including canthus

708

1.30

1.69

1.1

4.63

2.84

u/ml

0.58

338

Other diseases of liver

152

1243

1.23

1.69

1.1

2.31

3.72

u/ml

0.92

603

Other sexually transmitted chlamydial diseases

123

985

1.26

1.68

1.1

3.10

4.18

u/ml

0.49

510

Other noninflammatory disorders of vulva and perineum

104

815

1.28

1.68

1.1

4.86

4.95

u/ml

0.01

402

Primary_lymphoid and hematopoietic malignant neoplasms

1027

0.76

1.68

1.1

4.03

3.51

u/ml

0.08

526

Diabetic nephropathy, excluding more controls

499

0.68

1.68

1.2

1.1

6.92

2.38

u/ml

0.72

248

Complications associated with artificial fertilization

204

1.59

1.68

1.1

7.39

3.60

u/ml

0.37

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

127

1001

1.25

1.67

1.1

2.74

5.11

u/ml

1.87

592

Juvenile osteochondrosis

359

1.44

1.67

1.1

3.71

4.77

u/ml

0.30

178

Benign neoplasm: Rectum, anus and anal canal

718

1.30

1.67

1.1

2.11

2.43

u/ml

0.13

353

Cardiomyopathies, Primary/intrinsic

467

0.64

1.67

1.2

1.1

3.56

2.89

u/ml

0.10

240

Insulin, fast-acting (human)

109

1372

0.79

1.66

1.1

2.94

3.93

u/ml

0.46

703

Implicit bacterial Sepsis, including avohilmo

189

1875

0.84

1.66

1.1

3.54

3.50

u/ml

0.01

105

929

Other benign neoplasms of uterus

134

1.72

1.66

1.0

6.30

1.91

u/ml

0.49

Acute alcohol intoxication

157

1902

0.82

1.66

1.1

7.13

3.66

u/ml

1.30

950

Other mycoses, not elsewhere classified/unspecified, including avohilmo

112

1.81

1.66

1.0

12.50

3.75

u/ml

—

Other systemic involvement of connective tissue (FG)

199

1642

1.19

1.65

1.1

1.96

3.37

u/ml

1.03

100

783

Benign neoplasm of other and unspecified endocrine glands

746

1.29

1.65

1.0

1.1

2.29

3.30

u/ml

0.56

372

Focal epilepsy

132

1625

0.81

1.65

1.1

3.80

4.38

u/ml

0.14

852

Artrosis, including avohilmo

824

4133

1.09

1.65

1.1

3.20

3.71

u/ml

0.46

386

2012

Glomerular diseases

1091

0.77

1.65

1.1

5.22

4.36

u/ml

0.14

561

Sarcoidosis

100

782

1.28

1.64

1.1

3.95

2.45

u/ml

0.38

371

Obsessive-compulsive disorder

123

988

1.25

1.64

1.1

4.08

5.03

u/ml

0.26

525

Other deformities of toe(s)

150

1.68

1.64

1.0

1.1

1.14

2.68

u/ml

1.13

Testicular dysfunction

294

1.47

1.63

1.0

1.1

0.96

3.59

u/ml

2.26

157

Panniculitis affecting regions of neck and back

213

1.56

1.63

1.1

8.44

2.20

u/ml

0.60

105

Other systemic involvement of connective tissue

199

1677

1.19

1.62

1.1

1.96

3.67

u/ml

1.37

100

802

Benign neoplasms

1224

6205

1.07

1.62

1.1

3.39

4.33

u/ml

0.80

603

3213

Disorders of vitreous body

297

2456

1.15

1.61

1.1

2.71

3.29

u/ml

0.35

138

1149

Certain conditions originating in the perinatal period

187

1393

1.20

1.61

1.1

6.73

5.88

u/ml

0.26

116

849

Other disorders of Eustachian tube

198

1.58

1.61

1.1

3.80

4.80

u/ml

0.13

Struck by thrown, projected or falling objec

455

1.37

1.60

1.2

1.1

6.18

3.90

u/ml

0.43

243

Benign neoplasm: Choroid

254

1.50

1.60

1.0

1.1

1.62

2.32

u/ml

0.29

121

Benign neoplasm of eye and adnexa

506

1.35

1.60

1.0

1.1

2.03

3.46

u/ml

0.79

246

Other diseases of anus and rectum

204

1719

1.18

1.59

1.1

3.31

3.62

u/ml

0.12

858

Pleural plaque with presence of asbestos

2.07

1.59

1.1

5.00

0.72

u/ml

—

Coronary atherosclerosis

275

2003

0.86

1.59

1.1

4.37

2.93

u/ml

0.83

141

963

Fitting and adjustment of other devices

177

1300

1.20

1.59

1.1

3.25

2.99

u/ml

0.08

608

Foreign body in alimentary tract

354

1.42

1.59

1.1

3.44

4.89

u/ml

0.35

194

Disorders of gallbladder, biliary tract and pancreas

799

5406

0.92

1.58

1.1

3.86

3.71

u/ml

0.08

366

2622

Parkinson's disease, strict definition

275

0.54

1.58

1.1

1.49

1.88

u/ml

—

142

Autoimmune diseases

1196

6505

0.93

1.58

1.1

3.32

4.50

u/ml

2.05

621

3363

Chalazion

105

832

1.27

1.57

1.1

1.56

3.73

u/ml

2.76

412

Leiomyoma of uterus

514

3202

0.90

1.57

1.1

3.24

3.65

u/ml

0.24

216

1459

Exclusions for E4_PCOS_BROAD

196

1655

1.19

1.57

1.1

3.32

4.63

u/ml

0.50

880

Sacroiliitis, not elsewhere classified

492

1.35

1.56

1.0

1.1

4.71

3.91

u/ml

0.10

247

Dilated cardiomyopathy

410

0.63

1.55

1.2

1.1

4.07

2.23

u/ml

0.27

213

Infectious mononucleosis

153

1267

1.22

1.55

1.1

3.94

4.38

u/ml

0.13

100

677

Infectious mononucleosis, including avohilmo

153

1267

1.22

1.55

1.1

3.94

4.38

u/ml

0.13

100

677

Focal epilepsy, mode (most common among epilepsy diagnosis)

110

1370

0.80

1.55

1.1

2.78

3.88

u/ml

0.42

720

Polycystic ovarian syndrome, consortium definition

915

4848

1.08

1.55

1.1

3.43

4.44

u/ml

1.22

444

2362

Hypertensive diseases (excluding secondary)

586

3756

0.91

1.55

1.1

3.73

4.03

u/ml

0.17

308

1823

Focal epilepsy, strict definition

114

1414

0.80

1.55

1.1

2.86

4.20

u/ml

0.55

751

Cerebral cysts

501

1.35

1.55

1.1

3.48

4.00

u/ml

0.11

254

Other and unspecified injuries of lower leg

728

1.28

1.55

1.1

4.90

3.52

u/ml

0.27

379

Excessive earwax

506

4132

1.11

1.54

1.1

3.07

4.14

u/ml

1.13

264

2117

Testicular hypofunction

257

1.49

1.54

1.0

1.1

0.86

3.62

u/ml

2.08

136

Other specified disorders of external ear

130

1.70

1.53

1.0

1.1

2.35

1.68

u/ml

0.22

Anoxic brain damage

0.00

1.53

0.0

1.0

—

2.22

—

Congenital malformations of the respiratory system, including avohilmo

193

1.58

1.53

1.2

1.1

3.71

7.03

u/ml

0.62

118

Use of pramipexole

126

1023

1.23

1.52

1.1

2.58

2.86

u/ml

0.13

491

Retention of urine

113

1135

0.80

1.52

1.1

2.77

2.89

u/ml

0.04

570

Other diseases of intestine

667

1.29

1.52

1.1

2.20

2.96

u/ml

0.32

341

Separation of retinal layers (serosa)

233

1.51

1.52

1.1

2.06

2.44

u/ml

0.14

110

Varicose veins of other sites

374

1.40

1.52

1.0

1.1

1.67

3.03

u/ml

0.96

198

Diseases of arteries, arterioles and capillaries (FINNGEN)

123

1045

0.81

1.52

1.1

3.50

2.95

u/ml

0.14

494

Urethritis and urethral syndrome

123

1.72

1.52

1.3

1.0

1.27

2.99

u/ml

—

Other peripheral vertigo

391

1.39

1.51

1.1

3.35

2.30

u/ml

0.22

187

LeFortI or BSSO operation

426

1.37

1.51

1.1

4.28

3.86

u/ml

0.06

209

Acute alcohol intoxication, ICD10

139

1685

0.82

1.51

1.1

7.26

3.78

u/ml

1.15

852

Benign lipomatous neoplasm of other sites/unspecified

307

1.44

1.51

1.0

1.1

16.91

2.26

u/ml

0.47

149

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

256

0.54

1.51

1.0

3.60

4.12

u/ml

—

119

Endocrine, nutritional and metabolic diseases

1142

5373

1.07

1.51

1.1

3.77

4.57

u/ml

0.97

606

2758

Diseases of tongue

299

1.44

1.51

1.1

9.45

3.24

u/ml

0.58

126

Disorders of vitreous body and globe

303

2510

1.14

1.50

1.1

2.81

3.28

u/ml

0.28

142

1176

Trigeminal neuralgia

350

1.41

1.49

1.1

0.74

3.84

u/ml

2.79

160

Benign neoplasm of bone and articular cartilage

653

1.29

1.48

1.0

1.1

4.02

3.46

u/ml

0.10

320

Maternal care for other conditions predominantly related to pregnancy

336

2896

1.13

1.48

1.1

2.01

4.78

u/ml

3.53

167

1396

Emotional disorders starting during childhood or adolecense, excluding more controls

103

797

1.26

1.48

1.1

5.01

5.55

u/ml

0.14

472

Sequelae of injuries of upper limb

706

1.28

1.48

1.1

2.80

3.40

u/ml

0.21

348

Benign neoplasm: Adrenal gland

317

1.43

1.48

1.0

1.1

3.38

1.94

u/ml

0.43

151

Non-selective monoamine reuptake inhibitors

247

2050

1.16

1.48

1.1

2.51

3.23

u/ml

0.47

142

949

Other puerperal infections

136

1120

1.22

1.48

1.1

5.91

4.17

u/ml

0.38

553

Influenza and pneumonia

1256

7257

1.07

1.47

1.1

4.84

4.07

u/ml

0.74

717

3633

Viral warts

112

903

1.25

1.47

1.1

5.56

4.12

u/ml

0.28

461

Alzheimer’s disease, strict definition

247

0.59

1.45

1.0

0.07

1.02

u/ml

—

122

Inflammation of lacrimal passages (acute and unspecified)

1.89

1.45

1.2

1.1

2.35

2.64

u/ml

—

Reactive arthropathies

585

1.30

1.45

1.0

1.1

5.82

3.08

u/ml

0.48

283

Medial epicondylitis

236

1.49

1.45

1.1

0.83

3.22

u/ml

1.64

117

Convergence insufficiency and excess

133

1.68

1.44

1.2

1.1

2.85

3.75

u/ml

0.16

Other endocrine disorders

688

1.28

1.44

1.1

7.69

6.71

u/ml

0.15

422

Syncope and collapse

360

2669

1.13

1.44

1.1

5.39

3.87

u/ml

0.74

193

1356

Scleritis and episcleritis

473

1.34

1.43

1.1

2.69

2.23

u/ml

0.19

224

Cellulitis

207

1773

1.17

1.43

1.1

3.95

3.89

u/ml

0.02

113

903

Pterygium

1.98

1.43

1.0

1.1

0.19

2.17

u/ml

—

Other erythematous conditions

188

1.55

1.43

1.1

1.28

3.77

u/ml

1.77

5-aminosalicylic acid

209

1792

1.17

1.43

1.1

2.74

3.89

u/ml

0.67

859

Valvular operations

532

0.69

1.43

1.0

1.1

2.25

4.11

u/ml

1.08

284

Other abnormal auditory perceptions

1.85

1.43

1.3

1.0

5.00

2.19

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

692

1.28

1.43

1.1

8.16

3.85

u/ml

1.06

352

Alcoholic liver disease

401

0.65

1.43

1.1

4.35

2.00

u/ml

0.40

205

Excessive vomiting in pregnancy

116

943

1.24

1.43

1.1

1.33

4.76

u/ml

3.35

459

580

0.71

1.42

1.1

5.49

6.44

u/ml

0.11

388

Acute otitis externa, noninfective

1.84

1.42

1.2

1.0

0.38

2.67

u/ml

—

Impacted cerumen

534

1.32

1.42

1.1

3.85

3.73

u/ml

0.02

294

Ménière disease

379

1.38

1.42

1.1

4.42

2.46

u/ml

0.25

183

Benign intracranial hypertension

134

1.68

1.42

1.1

5.78

4.84

u/ml

—

Extracorporeal dialysis

277

0.57

1.42

1.0

1.1

1.95

3.54

u/ml

0.54

144

Parkinson's disease, excluding more controls

267

0.58

1.42

1.1

1.0

1.59

2.77

u/ml

—

131

Finngen Rheumatological endpoints

1034

6286

0.93

1.41

1.1

3.44

4.34

u/ml

1.12

524

3132

Cholecystectomy

580

4492

1.10

1.41

1.1

4.65

3.43

u/ml

0.74

264

2127

Seborrhoeic keratosis

129

1061

1.22

1.40

1.1

1.28

2.66

u/ml

2.26

490

Impetigo

554

1.31

1.40

1.2

1.1

4.99

4.84

u/ml

0.03

312

Other female pelvic inflammatory diseases

139

1153

1.21

1.40

1.1

3.36

4.23

u/ml

0.25

545

Congenital mitral valve regurgitation

0.00

1.39

0.0

1.1

—

7.78

—

Secondary and unspecified malignant neoplasm of lymph nodes

362

0.63

1.39

1.1

4.28

4.21

u/ml

0.01

181

Malignant neoplasm of breast, HER-negative

968

0.78

1.39

1.0

1.1

4.86

2.72

u/ml

0.67

441

Vestibular neuronitis

432

1.35

1.39

1.1

2.99

2.48

u/ml

0.14

214

Disorders of ocular muscles, binocular movement, accommodation and refraction

594

5387

1.09

1.39

1.1

5.73

4.38

u/ml

0.48

309

2802

519

0.70

1.39

1.1

5.58

6.60

u/ml

0.11

349

Systemic connective tissue disorders

253

2206

1.15

1.39

1.1

1.71

3.71

u/ml

2.59

135

1065

Polyneuropathies and other disorders of the peripheral nervous system

114

927

1.23

1.39

1.1

4.61

3.05

u/ml

0.42

456

Malignant neoplasm of head and neck

250

0.56

1.39

1.0

1.1

7.02

2.04

u/ml

—

122

Obesity due to excess calories

550

5018

1.10

1.38

1.1

4.98

4.01

u/ml

0.42

289

2462

Basal cell carcinoma

161

1304

0.84

1.38

1.1

0.56

2.81

u/ml

9.68

631

Contact urticaria

2.69

1.38

1.3

1.0

0.92

1.42

u/ml

—

Exposure to other specified electric current

236

0.54

1.38

1.0

1.1

0.45

4.64

u/ml

—

129

L02BG Aromatase inhibitors

125

1496

0.82

1.38

1.1

2.09

3.39

u/ml

1.23

677

Caries of dentine, including avohilmo

783

3692

1.08

1.38

1.1

3.37

4.06

u/ml

0.64

431

1824

Other and unspecified injuries of ankle and foot

442

1.35

1.38

1.1

8.94

3.46

u/ml

0.37

224

Synovial cyst of popliteal space [Baker]

305

1.42

1.38

1.2

1.0

1.79

3.07

u/ml

0.60

152

Other and specified injuries of hip and thigh

104

1.75

1.37

1.1

1.0

0.89

3.69

u/ml

—

Viral meningitis, including avohilmo

340

1.39

1.37

1.1

5.06

3.72

u/ml

0.23

176

conjunctival haemorrhage

264

1.44

1.36

1.0

1.1

5.80

1.98

u/ml

0.62

130

Pediculosis, acariasis and other infestations, including avohilmo

243

2118

1.15

1.36

1.1

3.91

4.77

u/ml

0.36

130

1122

Fibroblastic disorders

129

1066

1.21

1.35

1.0

0.96

2.62

u/ml

4.21

509

Tongue abnormality

273

1.44

1.35

1.1

1.86

2.99

u/ml

0.42

136

Malignant neoplasm of prostate, including Hilmo

536

0.77

1.35

1.0

1.1

1.57

2.62

u/ml

0.72

276

Monoamine oxidase A inhibitors

627

1.28

1.35

1.1

1.69

2.72

u/ml

0.50

304

Dizziness and giddiness

687

4921

1.09

1.34

1.1

2.93

4.10

u/ml

0.87

357

2417

Benign neoplasm: Bones of skull and face

2.07

1.34

1.0

7.67

2.65

u/ml

—

Polyarthrosis

101

732

1.24

1.34

1.1

1.0

1.91

2.96

u/ml

0.53

322

Eustachian salpingitis and obstruction

114

933

1.23

1.34

1.1

3.78

3.92

u/ml

0.03

475

Cardiovascular diseases

1062

5270

1.07

1.33

1.1

3.66

4.65

u/ml

1.19

567

2750

Helminthiases

113

1.70

1.33

1.2

1.0

3.32

5.15

u/ml

0.34

Diseases of pulp and periapical tissues, including avohilmo

1098

6057

0.94

1.33

1.1

4.66

4.01

u/ml

0.56

575

3086

Angina pectoris

207

1592

0.86

1.32

1.1

1.89

2.81

u/ml

0.79

767

Fracture at wrist and hand level

370

3306

1.12

1.32

1.1

6.91

3.83

u/ml

1.66

210

1722

Use of donepezil

211

0.54

1.32

1.0

1.1

0.30

0.99

u/ml

—

106

Benign neoplasm of colon, rectum, anus and anal canal

354

2671

1.12

1.32

1.1

2.05

3.02

u/ml

1.05

165

1275

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

191

1502

0.86

1.31

1.1

1.25

2.73

u/ml

2.35

725

Perforation of tympanic membrane

692

1.26

1.31

1.1

3.73

3.40

u/ml

0.08

352

Other complications of labour and delivery, not elsewhere classified

178

1840

0.85

1.31

1.1

4.57

4.83

u/ml

0.06

909

Measles

1.79

1.30

1.1

9.17

2.55

u/ml

0.73

Measles, including avohilmo

1.79

1.30

1.1

9.17

2.55

u/ml

0.73

Achilles tendinitis

648

1.27

1.30

1.1

3.07

2.60

u/ml

0.11

310

Other diseases of peritoneum

209

1.49

1.30

1.0

1.1

3.96

1.95

u/ml

0.35

100

Viral conjunctivitis, including avohilmo

369

1.37

1.30

1.1

3.56

4.10

u/ml

0.09

187

KRA_PSY_EATING, excluding more controls

154

1289

1.19

1.30

1.1

4.93

4.49

u/ml

0.11

667

Coeliac disease

118

972

1.22

1.30

1.1

5.63

4.24

u/ml

0.41

496

Peripheral arterial reconstruction

319

0.63

1.29

1.2

1.1

3.69

1.69

u/ml

0.30

157

Supervision of high-risk pregnancy

268

1830

0.88

1.29

1.1

2.68

5.17

u/ml

2.53

123

862

Spirochaetal infections, other/unspecified

482

1.31

1.28

1.0

1.1

6.75

3.46

u/ml

0.43

240

Parkinson's disease, strict definition, excluding more controls

239

0.58

1.28

1.1

1.49

1.40

u/ml

—

118

Benign neoplasm: Transverse colon

344

1.37

1.28

1.1

0.62

2.03

u/ml

3.02

176

Alzheimer’s disease (Late onset)

180

0.55

1.27

1.0

0.02

0.85

u/ml

—

Viral Sepsis

148

1248

1.19

1.27

1.1

6.83

4.20

u/ml

0.83

636

Melanocytic naevi of lower limb, including hip

345

1.37

1.27

1.1

4.20

3.80

u/ml

0.07

174

Disorders of lacrimal system and orbit in diseases classified elsewhere

146

1.59

1.27

1.1

0.41

2.02

u/ml

—

Other hammer toe(s) (acquired)

518

1.28

1.27

1.1

2.56

2.87

u/ml

0.10

241

Chronic apical periodontitis

1134

6759

0.94

1.26

1.1

3.45

4.09

u/ml

0.76

580

3368

Hypertension, essential

705

4307

0.92

1.26

1.1

3.57

3.63

u/ml

0.03

363

2016

Pre-eclampsia or eclampsia

191

2209

0.86

1.26

1.1

2.86

4.31

u/ml

0.98

1061

Spondylosis

368

2581

1.11

1.25

1.1

3.55

3.14

u/ml

0.19

164

1193

Basal cell carcinoma, including Hilmo

177

1398

0.86

1.25

1.1

0.72

2.78

u/ml

7.97

674

Problems related to lifestyle

1002

0.80

1.25

1.1

11.39

4.19

u/ml

0.57

504

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.88

1.25

1.5

1.0

2.82

2.58

u/ml

—

Enlarged lymph nodes

142

1196

1.19

1.24

1.1

8.84

3.69

u/ml

0.69

605

Collagenous colitis

564

1.28

1.24

1.1

1.00

4.45

u/ml

4.31

283

Seropositive rheumatoid arthritis

116

1390

0.83

1.24

1.0

1.1

2.02

3.00

u/ml

0.36

649

Infections, IBD-co-morbidities

146

863

1.19

1.24

1.0

1.1

6.34

3.84

u/ml

0.35

448

Benign neoplasm: Scapula and long bones of upper limb

1.93

1.24

1.0

1.1

13.12

1.43

u/ml

—

Other and unspecified epidermal thickening

163

1.55

1.24

1.1

1.0

6.80

4.71

u/ml

0.27

Sequelae of other external causes

338

1.37

1.23

1.2

1.1

4.38

3.54

u/ml

0.14

168

Superficial injury of thorax

123

1024

1.20

1.23

1.2

1.1

3.39

3.49

u/ml

0.03

514

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

237

1.44

1.22

1.0

9.14

3.13

u/ml

0.90

112

Implicit viral Sepsis

147

1245

1.18

1.21

1.1

6.36

4.21

u/ml

0.65

634

Retained placenta and membranes, without haemorrhage

121

1008

1.21

1.1

3.55

3.65

u/ml

0.02

460

Glomerulonephritis

605

0.74

1.21

1.0

1.1

4.11

3.89

u/ml

0.03

321

Other specified/unspecified disorders of bone/cartilage

140

1.58

1.20

1.1

6.05

3.41

u/ml

—

Radial styloid tenosynovitis [de Quervain]

470

1.30

1.20

1.0

1.1

1.82

3.03

u/ml

0.72

227

Spermatocele

213

1.46

1.20

1.0

1.1

3.68

2.72

u/ml

0.22

118

Other bursopathies

647

1.26

1.20

1.1

1.84

2.95

u/ml

0.83

311

Necrosis of pulp, including avohilmo

581

6220

0.92

1.20

1.1

5.06

4.00

u/ml

0.62

298

3043

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

117

1.65

1.19

1.2

1.1

5.81

3.49

u/ml

0.39

Infections of genitourinary tract in pregnancy

939

0.80

1.18

1.1

4.69

5.32

u/ml

0.11

477

Malignant neoplasm of bladder

1.75

1.18

1.0

1.1

0.33

1.24

u/ml

—

Other and unspecified erythematous conditions

173

1.51

1.18

1.1

1.34

3.89

u/ml

1.57

Malignant neoplasm of breast, ER-negative, including Hilmo

1096

0.82

1.18

1.0

1.1

4.35

2.84

u/ml

0.52

501

Delivery, wide proxy

304

1808

0.89

1.18

1.1

4.51

4.78

u/ml

0.10

168

933

Ventricular septal defect, a heart condition

367

0.67

1.18

1.1

6.05

7.38

u/ml

0.20

234

Other disorders of fluid, electrolyte and acid-base balance

122

1370

0.84

1.17

1.1

2.70

3.29

u/ml

0.27

661

Scabies, including avohilmo

220

1929

1.14

1.17

1.1

3.64

4.80

u/ml

0.50

117

1029

Corneal degeneration

1.95

1.17

1.2

1.0

5.48

2.13

u/ml

—

Benign neoplasm: Rectum

631

1.25

1.17

1.1

2.25

2.56

u/ml

0.11

316

Atrial septal defect, secundum type

355

0.67

1.17

1.1

1.70

7.61

u/ml

4.63

229

Superficial injury of wrist and hand

266

2363

1.13

1.16

1.1

3.40

4.33

u/ml

0.49

139

1267

Speech therapy

174

1501

1.16

1.1

3.04

3.33

u/ml

0.09

732

Other specified/unspecified arthritis

235

2071

1.14

1.16

1.1

4.42

3.89

u/ml

0.17

117

1014

Other congenital malformations, including avohilmo

175

1511

1.16

1.1

7.36

4.77

u/ml

0.38

108

810

Benign neoplasm: Small intestine

110

1.64

1.15

1.2

1.0

2.06

2.22

u/ml

0.05

Explicit bacterial Sepsis

588

0.75

1.15

1.0

1.1

6.51

4.35

u/ml

0.24

310

Fracture of shoulder and upper arm

230

2603

0.88

1.15

1.1

5.53

4.10

u/ml

0.49

123

1374

Sudden idiopathic hearing loss

465

1.29

1.14

1.1

7.13

2.97

u/ml

0.93

240

Divergent concomitant strabismus

621

0.75

1.14

1.1

3.47

4.67

u/ml

0.40

304

Sequelae of infectious and parasitic diseases, including avohilmo

439

1.30

1.14

1.1

3.24

2.29

u/ml

0.28

208

Burn and corrosion of wrist and hand

370

1.33

1.13

1.1

6.74

4.46

u/ml

0.30

202

Major anomalies of jaw size

225

1.44

1.13

1.3

1.1

3.57

4.60

u/ml

0.18

116

Hydronephrosis

575

0.75

1.13

1.1

5.06

2.96

u/ml

0.32

288

Non-small cell lung cancer, including Hilmo

311

0.66

1.13

1.0

1.1

4.61

2.32

u/ml

—

155

Bacterial intestinal infections, IBD co-morbidities

118

988

1.20

1.13

1.1

6.59

3.65

u/ml

0.35

496

Congenital malformations of cardiac septa

816

0.79

1.12

1.1

7.23

5.71

u/ml

0.24

489

Scleritis

1.73

1.12

1.0

3.76

3.41

u/ml

—

Persons with potential health hazards related to communicable diseases

569

5213

1.08

1.12

1.1

4.03

4.70

u/ml

0.44

296

2778

Hyperplasia of prostate

155

744

1.17

1.11

1.1

0.85

2.86

u/ml

4.31

391

Glaucoma-related operations

119

1.60

1.11

1.1

1.0

0.75

1.55

u/ml

0.73

Contusion of toe(s) with damage to nail

1.69

1.11

1.1

1.0

7.28

2.91

u/ml

—

Female genital prolapse

210

1019

1.15

1.11

1.0

1.1

3.85

3.74

u/ml

0.03

483

Ischaemic heart disease, wide definition

401

2713

0.91

1.11

1.1

3.50

3.03

u/ml

0.27

197

1285

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

596

0.75

1.11

1.1

2.72

2.43

u/ml

0.07

300

Other malignant neoplasms of skin (=non-melanoma skin cancer)

177

1385

0.87

1.11

1.1

1.22

2.82

u/ml

2.38

670

Injury of eye and orbit

156

1342

1.17

1.10

1.1

5.72

3.95

u/ml

0.47

687

Embedded teeth, including avohilmo

152

1306

1.17

1.10

1.1

6.09

4.36

u/ml

0.20

709

Bicipital tendinitis

226

1.42

1.10

1.1

0.94

2.41

u/ml

1.73

110

Sequelae of infectious and parasitic diseases

433

1.30

1.10

1.1

3.37

2.31

u/ml

0.30

206

Ulcer of lower limb, not elsewhere classified

469

0.72

1.09

1.2

1.1

5.24

2.46

u/ml

0.54

232

Complications of labour and delivery

728

3766

1.08

1.09

1.1

4.44

4.18

u/ml

0.09

365

1828

Intermittent heterotropia

749

0.78

1.09

1.1

12.47

5.81

u/ml

0.47

446

Vitreous haemorrhage

457

0.72

1.09

1.1

3.97

1.88

u/ml

0.24

238

Pre-eclampsia

184

2105

0.87

1.08

1.1

2.95

4.24

u/ml

0.79

1013

Foreign body entering into or through eye or natural orifice

630

1.24

1.08

1.1

3.64

4.63

u/ml

0.26

333

Episcleritis

408

1.31

1.08

1.1

2.22

2.24

u/ml

0.01

193

Diseases of pulp and periapical tissues and dental caries

608

2884

1.08

1.1

4.04

3.85

u/ml

0.10

317

1398

Other hearing loss

121

988

1.19

1.07

1.1

4.21

3.38

u/ml

0.27

490

Other specified/unspecified spondylopathies

1.87

1.07

1.0

0.64

1.84

u/ml

—

Anogenital herpesviral [herpes simplex] infection

776

1.22

1.07

1.1

4.25

3.66

u/ml

0.11

394

Other diseases of gallbladder

169

1.49

1.07

1.1

0.86

2.06

u/ml

—

Other and unspecified corneal deformities and disorders

194

1.45

1.07

1.1

4.32

1.87

u/ml

0.62

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

112

1331

0.84

1.07

1.0

1.1

2.09

3.05

u/ml

0.34

628

Maternal care related to the fetus and amniotic cavity and possible delivery problems

629

3421

1.08

1.07

1.1

4.60

4.50

u/ml

0.05

297

1661

Procedures for purposes other than remedying health state

153

1.52

1.07

1.2

1.0

1.05

2.75

u/ml

—

Other disorders of prostate

1.76

1.07

1.1

0.06

2.52

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

784

5289

0.94

1.07

1.1

3.10

3.73

u/ml

0.61

392

2541

Crossbite

134

1052

1.18

1.06

1.1

5.23

5.50

u/ml

0.07

633

Other bacterial intestinal infections

117

986

1.19

1.06

1.1

6.34

3.39

u/ml

0.35

497

Intestinal malabsorption

305

1.35

1.05

1.0

1.1

6.25

2.98

u/ml

0.42

158

Varicose veins

327

2730

0.90

1.05

1.0

1.1

2.41

3.15

u/ml

0.61

140

1253

Primary hyperparathyroidism

418

1.30

1.05

1.1

4.08

2.88

u/ml

0.26

202

Hypertrophic disorders of skin

561

1.25

1.05

1.1

1.42

4.06

u/ml

2.97

285

Spinal stenosis

246

1610

1.13

1.05

1.1

2.36

2.62

u/ml

0.16

125

730

Event of undetermined intent

597

1.25

1.05

1.1

5.36

3.76

u/ml

0.41

302

Disorders of eyelid in diseases classified elsewhere

195

1.45

1.05

1.2

1.1

7.76

2.81

u/ml

0.82

Other disorders of veins

322

2864

1.11

1.05

1.1

3.37

3.62

u/ml

0.10

152

1342

Car occupant injured in other and unspecified transport accidents

220

1948

1.13

1.04

1.1

5.93

4.45

u/ml

0.26

101

997

Retinal detachments and breaks

175

1525

1.15

1.04

1.1

2.95

2.85

u/ml

0.04

724

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

321

3544

0.90

1.04

1.1

4.49

4.11

u/ml

0.15

165

1783

Pityriasis lichenoides chronica

2.32

1.04

1.0

1.1

7.31

2.10

u/ml

—

Postdysenteric arthropathy

1.86

1.04

1.2

1.0

2.93

3.65

u/ml

—

Graves ophthalmopathy

146

1.52

1.04

1.0

1.1

0.41

2.27

u/ml

—

Other factor of the environment

1.75

1.03

1.2

1.0

1.41

3.95

u/ml

—

Other specified/unspecified bacterial intestinal infections

332

1.33

1.03

1.1

12.76

3.23

u/ml

0.51

168

Malignant neoplasm of corpus uteri, including Hilmo

276

0.65

1.03

1.1

2.45

3.33

u/ml

—

126

Other eating disorders

780

1.21

1.03

1.1

3.34

5.62

u/ml

0.98

432

Other inflammation of vagina/vulva

412

1.30

1.02

1.0

1.56

4.81

u/ml

2.12

195

Other arrhythmias

642

4464

1.07

1.02

1.1

3.18

3.90

u/ml

0.69

333

2168

Chromosomal abnormalities, not elsewhere classified

355

0.69

1.01

1.2

1.1

3.95

6.52

u/ml

0.35

229

Abscess of external ear

1.67

1.01

1.0

1.1

1.75

1.84

u/ml

—

Other superficial mycoses, including avohilmo

138

1186

1.17

1.01

1.1

3.92

3.90

u/ml

0.01

602

Obstructed labour due to maternal pelvic abnormality

119

1010

1.18

1.01

1.0

1.1

2.11

2.93

u/ml

0.46

445

Corneal ulcer

180

1577

1.14

1.01

1.1

7.20

3.51

u/ml

1.40

778

Colorectal cancer, including Hilmo

878

0.82

1.01

1.1

1.0

3.84

2.66

u/ml

0.35

412

Other/unspecified seropositive rheumatoid arthritis

114

1344

0.85

1.01

1.0

1.1

2.06

3.02

u/ml

0.35

634

Early lumbar disc prolapse, operated

135

1159

1.17

1.00

1.1

3.49

3.58

u/ml

0.03

559

Seropositive rheumatoid arthritis, wide

116

1365

0.85

1.00

1.0

1.1

2.02

3.08

u/ml

0.40

641

Atrial fibrillation and flutter with reimbursement

121

897

0.85

1.00

1.1

3.46

2.96

u/ml

0.19

414

Other misadventures during surgical and medical care

107

1.60

1.00

1.2

1.1

0.43

2.49

u/ml

—

Other congenital malformations of the digestive system, including avohilmo

597

1.24

0.99

1.1

6.06

5.86

u/ml

0.03

359

Need for other prophylactic measures

396

1.29

0.99

1.1

0.77

3.30

u/ml

3.73

217

Primary open-angle glaucoma

708

1.21

0.99

1.0

1.1

1.35

2.02

u/ml

0.73

351

Any mental disorder

1187

5640

1.05

0.99

1.1

5.12

3.83

u/ml

1.06

637

2772

Adrenogenital disorders

0.00

0.98

0.0

1.0

—

4.56

—

Osteosarcoma, including Hilmo

0.00

0.98

0.0

1.0

—

2.29

—

159

1386

1.15

0.98

1.1

3.89

4.24

u/ml

0.09

662

Tooth eruption problems

279

2430

1.11

0.98

1.1

4.92

5.11

u/ml

0.03

170

1380

Rheumatic fever incl heart disease

1.67

0.98

1.1

1.0

1.00

2.82

u/ml

—

Other and unspecified nonscarring hair loss

1.77

0.98

1.1

1.0

2.50

3.08

u/ml

—

Dental caries, including avohilmo

670

3200

1.07

0.97

1.1

3.51

3.97

u/ml

0.32

353

1553

Other diseases of pleura

208

1600

1.13

0.97

1.1

4.10

3.78

u/ml

0.13

106

803

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

568

1.24

0.97

1.1

5.04

4.75

u/ml

0.05

328

Small cell lung cancer

0.00

0.97

0.0

1.1

—

1.51

—

Small cell lung cancer, including Hilmo

0.00

0.97

0.0

1.1

—

1.51

—

Postpartum haemorrhage due to anatomy

170

1490

1.15

0.97

1.1

4.34

4.28

u/ml

0.01

739

Malignant melanoma of skin

458

0.74

0.97

1.1

1.99

2.34

u/ml

0.09

220

Other, unspecified and serous retinal detachments

124

1.54

0.97

1.0

1.1

8.82

2.00

u/ml

—

Hydrocele

424

1.28

0.96

1.1

3.07

3.56

u/ml

0.08

240

Special screening examination for other diseases and disorders

104

876

1.19

0.96

1.2

1.0

3.58

3.54

u/ml

0.01

405

SLE (Finngen)

235

0.63

0.96

1.1

11.75

3.70

u/ml

—

111

Mixed conductive and sensorineural hearing loss

469

1.26

0.96

1.1

6.08

2.62

u/ml

0.69

242

Chondromalacia

174

1.45

0.95

1.2

1.1

5.14

2.44

u/ml

—

Other anaemias

173

1841

0.88

0.95

1.1

2.24

3.41

u/ml

1.10

932

Alopecia areata

242

1.37

0.95

1.1

12.14

5.71

u/ml

0.60

126

Viral meningitis

320

1.32

0.95

1.0

1.1

5.43

3.45

u/ml

0.34

164

Diplopia

750

1.20

0.95

1.1

5.17

3.30

u/ml

0.36

367

Infections of breast associated with childbirth

444

1.27

0.95

1.1

1.52

4.11

u/ml

1.85

210

Other and unspecified follicular disorders

320

1.32

0.95

1.1

2.50

3.59

u/ml

0.35

163

Myopia

176

1549

1.14

0.95

1.1

5.41

4.26

u/ml

0.12

789

Chronic iridocyclitis

317

0.69

0.95

1.0

1.1

7.76

3.06

u/ml

0.36

166

Rheumatoid arthritis, including avohilmo

207

2326

0.89

0.95

1.1

2.68

3.39

u/ml

0.35

105

1105

Hidradenitis suppurativa

409

0.73

0.94

1.2

1.1

11.81

3.90

u/ml

0.55

203

Mixed and other personality disorders

790

0.81

0.94

1.1

4.51

3.54

u/ml

0.20

388

Helminthiases, including avohilmo

462

1.26

0.94

1.2

1.1

4.03

5.74

u/ml

0.40

248

Malignant neoplasm of ovary

197

0.61

0.94

1.0

1.1

0.41

2.71

u/ml

—

Other abnormal immunological findings in serum

175

1.44

0.94

1.0

1.1

2.26

7.10

u/ml

1.49

Persons encountering health services for specific procedures, not carried out

743

1.20

0.93

1.1

5.93

3.75

u/ml

0.36

362

Premenstrual syndrome

167

1.45

0.93

1.0

1.1

1.76

4.42

u/ml

1.02

Rheumatoid arthritis

175

1757

0.88

0.93

1.1

2.87

3.43

u/ml

0.21

809

Other benign neoplasms of skin

254

2287

1.11

0.93

1.1

3.29

3.28

u/ml

0.00

123

1102

Nontraumatic intracranial haemmorrhage

645

0.79

0.93

1.1

2.82

2.59

u/ml

0.05

319

Disorder of the sleep-wake schedule

184

1.43

0.92

1.1

3.44

6.17

u/ml

0.39

109

Symptoms and signs involving emotional state

278

1.34

0.92

1.1

3.62

4.86

u/ml

0.35

135

Pregnancy, childbirth and the puerperium

272

1574

0.90

0.92

1.1

5.34

4.83

u/ml

0.17

149

814

Nerve, nerve root and plexus disorders

1056

6016

1.05

0.92

1.1

2.91

3.95

u/ml

1.82

514

2930

Palmar fascial fibromatosis [Dupuytren]

392

1.28

0.91

1.0

1.1

0.53

2.86

u/ml

2.88

198

Short stature, not elsewhere classified

473

1.25

0.91

1.1

8.61

7.63

u/ml

0.12

315

Other/unspecified enthesopathies, not elsewhere classified

428

1.27

0.91

1.2

1.1

3.63

3.07

u/ml

0.11

211

Mumps

151

1.47

0.91

1.0

1.1

6.43

2.69

u/ml

—

Diverticular disease of intestine

471

2712

1.08

0.90

1.0

1.1

2.23

3.28

u/ml

1.50

212

1283

Pain, not elsewhere classified

275

2491

1.11

0.90

1.1

4.03

4.06

u/ml

0.01

134

1259

Ischemic heart diseases

578

3685

0.93

0.90

1.1

3.59

3.78

u/ml

0.11

272

1801

Nontoxic goitre/thyroid nodule

171

1507

1.14

0.90

1.0

1.1

1.27

3.13

u/ml

4.58

710

Streptococcal septicaemia

429

0.74

0.90

1.0

1.1

3.74

4.34

u/ml

0.09

231

Abnormal results of function studies

609

1.22

0.90

1.1

3.22

3.93

u/ml

0.15

300

Gonarthrosis,primary

517

3351

0.93

0.90

1.1

2.32

3.05

u/ml

1.01

250

1515

Benign neoplasm: Other and unspecified parts of mouth

143

1.48

0.90

1.0

0.23

2.38

u/ml

—

Presence of other functional implants

260

1971

0.90

1.1

2.73

3.27

u/ml

0.31

115

961

Other and unspecified anaemias

172

1827

0.88

0.90

1.1

2.24

3.43

u/ml

1.13

926

Respiratory insufficiency

118

1.52

0.89

1.1

1.0

5.64

1.50

u/ml

—

Septal defects

778

0.81

0.89

1.1

7.41

5.78

u/ml

0.26

460

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dog dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS